,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
493,GO_Biological_Process_2017b,negative regulation of hydrogen peroxide metabolic process (GO:0010727),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PRKN
434,GO_Biological_Process_2017b,ribosome-associated ubiquitin-dependent protein catabolic process (GO:1990116),2/192,0.010070044927691,0.0529076577039536,0,0,14.882706766917291,68.4335150764336,PRKN;BTBD9
435,GO_Biological_Process_2017b,mitochondria-associated ubiquitin-dependent protein catabolic process (GO:0072671),2/193,0.0101707617544195,0.0529076577039536,0,0,14.804038893044128,67.92445631361214,PRKN;BTBD9
436,GO_Biological_Process_2017b,transcription factor catabolic process (GO:0036369),2/194,0.0102719315911298,0.0529076577039536,0,0,14.726190476190476,67.42150972922664,PRKN;BTBD9
437,GO_Biological_Process_2017b,"heparan sulfate proteoglycan biosynthetic process, linkage to polypeptide (GO:0015013)",1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,EXT1
438,GO_Biological_Process_2017b,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,PTPRD
439,GO_Biological_Process_2017b,regulation of mitochondrial DNA metabolic process (GO:1901858),1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,PRKN
440,GO_Biological_Process_2017b,"heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,EXT1
433,GO_Biological_Process_2017b,protein denaturation involved in proteasomal ubiquitin-dependent protein catabolic process (GO:1902376),2/192,0.010070044927691,0.0529076577039536,0,0,14.882706766917291,68.4335150764336,PRKN;BTBD9
441,GO_Biological_Process_2017b,protein denaturation (GO:0030164),1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,PRKN
443,GO_Biological_Process_2017b,prosthetic group catabolic process (GO:0051190),1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,PRKN
444,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process (GO:2000377),1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,PRKN
445,GO_Biological_Process_2017b,negative regulation of protein targeting to mitochondrion (GO:1903215),1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,PRKN
446,GO_Biological_Process_2017b,positive regulation of synaptic transmission (GO:0050806),1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,BTBD9
447,GO_Biological_Process_2017b,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,PRKN
448,GO_Biological_Process_2017b,regulation of cristae formation (GO:1903850),1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,PRKN
449,GO_Biological_Process_2017b,PSII associated light-harvesting complex II catabolic process (GO:0010304),1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,PRKN
442,GO_Biological_Process_2017b,histone catabolic process (GO:0036205),1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,PRKN
432,GO_Biological_Process_2017b,lipopolysaccharide biosynthetic process (GO:0009103),1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,EXT1
431,GO_Biological_Process_2017b,regulation of protein processing involved in protein targeting to mitochondrion (GO:1903216),1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,PRKN
430,GO_Biological_Process_2017b,mammary gland morphogenesis (GO:0060443),1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,NRG1
413,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response (GO:0006990),1/11,0.0087669723009575,0.0529076577039536,0,0,133.16,630.7474630602054,SMAD9
414,GO_Biological_Process_2017b,regulation of glucose metabolic process (GO:0010906),1/11,0.0087669723009575,0.0529076577039536,0,0,133.16,630.7474630602054,PRKN
415,GO_Biological_Process_2017b,membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,KCND3
416,GO_Biological_Process_2017b,regulation of protein ubiquitination (GO:0031396),1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,PRKN
417,GO_Biological_Process_2017b,negative regulation of synaptic transmission (GO:0050805),1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,BTBD9
418,GO_Biological_Process_2017b,regulation of glycogen metabolic process (GO:0070873),1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,PRKN
419,GO_Biological_Process_2017b,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,PRKN
420,GO_Biological_Process_2017b,regulation of protein monoubiquitination (GO:1902525),1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,PRKN
421,GO_Biological_Process_2017b,regulation of protein polyubiquitination (GO:1902914),1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,PRKN
422,GO_Biological_Process_2017b,regulation of synaptic activity (GO:0060025),1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,BTBD9
423,GO_Biological_Process_2017b,membrane repolarization during bundle of His cell action potential (GO:0086050),1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,KCND3
424,GO_Biological_Process_2017b,ventricular cardiac muscle cell differentiation (GO:0055012),1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,NRG1
425,GO_Biological_Process_2017b,"regulation of synaptic transmission, dopaminergic (GO:0032225)",1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,BTBD9
426,GO_Biological_Process_2017b,cardiac muscle cell myoblast differentiation (GO:0060379),1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,NRG1
427,GO_Biological_Process_2017b,regulation of glycolytic fermentation to ethanol (GO:2001154),1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,PRKN
428,GO_Biological_Process_2017b,regulation of glucose catabolic process to lactate via pyruvate (GO:1904023),1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,PRKN
429,GO_Biological_Process_2017b,regulation of synaptic vesicle transport (GO:1902803),1/12,0.0095603900128118,0.0529076577039536,0,0,121.04848484848485,562.8907982194623,PRKN
450,GO_Biological_Process_2017b,rhodopsin catabolic process (GO:0046155),1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,PRKN
412,GO_Biological_Process_2017b,regulation of UDP-glucose catabolic process (GO:0010904),1/11,0.0087669723009575,0.0529076577039536,0,0,133.16,630.7474630602054,PRKN
451,GO_Biological_Process_2017b,cardiac muscle cell development (GO:0055013),1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,NRG1
453,GO_Biological_Process_2017b,positive regulation of ERAD pathway (GO:1904294),1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,PRKN
475,GO_Biological_Process_2017b,regulation of mitochondrion organization (GO:0010821),1/15,0.0119370735063595,0.0529076577039536,0,0,95.0952380952381,421.0918230074216,PRKN
476,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to menadione (GO:0036252),1/15,0.0119370735063595,0.0529076577039536,0,0,95.0952380952381,421.0918230074216,SMAD9
477,GO_Biological_Process_2017b,"regulation of synaptic transmission, GABAergic (GO:0032228)",1/15,0.0119370735063595,0.0529076577039536,0,0,95.0952380952381,421.0918230074216,BTBD9
478,GO_Biological_Process_2017b,membrane repolarization during SA node cell action potential (GO:0086052),1/15,0.0119370735063595,0.0529076577039536,0,0,95.0952380952381,421.0918230074216,KCND3
479,GO_Biological_Process_2017b,mesenchymal cell differentiation involved in mammary gland development (GO:0060610),1/15,0.0119370735063595,0.0529076577039536,0,0,95.0952380952381,421.0918230074216,NRG1
480,GO_Biological_Process_2017b,regulation of gluconeogenesis (GO:0006111),1/15,0.0119370735063595,0.0529076577039536,0,0,95.0952380952381,421.0918230074216,PRKN
481,GO_Biological_Process_2017b,protein catabolic process in the vacuole (GO:0007039),1/15,0.0119370735063595,0.0529076577039536,0,0,95.0952380952381,421.0918230074216,PRKN
474,GO_Biological_Process_2017b,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),1/15,0.0119370735063595,0.0529076577039536,0,0,95.0952380952381,421.0918230074216,PRKN
482,GO_Biological_Process_2017b,positive regulation of protein localization to plasma membrane (GO:1903078),1/15,0.0119370735063595,0.0529076577039536,0,0,95.0952380952381,421.0918230074216,PRKN
484,GO_Biological_Process_2017b,regulation of reactive oxygen species biosynthetic process (GO:1903426),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PRKN
485,GO_Biological_Process_2017b,6-sulfoquinovose(1-) catabolic process to 3-sulfopropanediol(1-) (GO:0061721),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
486,GO_Biological_Process_2017b,nucleoside phosphate metabolic process (GO:0006753),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
487,GO_Biological_Process_2017b,D-tagatose 6-phosphate metabolic process (GO:2001058),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
488,GO_Biological_Process_2017b,xylulose 5-phosphate metabolic process (GO:0051167),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
489,GO_Biological_Process_2017b,phosphate-containing compound metabolic process (GO:0006796),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
490,GO_Biological_Process_2017b,glucose 1-phosphate metabolic process (GO:0019255),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
483,GO_Biological_Process_2017b,positive regulation of G-quadruplex DNA binding (GO:1905495),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PRKN
473,GO_Biological_Process_2017b,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),2/207,0.0116280484625966,0.0529076577039536,0,0,13.78327526132404,61.395327182910165,PRKN;BTBD9
472,GO_Biological_Process_2017b,regulation of superoxide metabolic process (GO:0090322),1/14,0.011145440218903,0.0529076577039536,0,0,102.4153846153846,460.53380130419424,PRKN
471,GO_Biological_Process_2017b,positive regulation of sarcomere organization (GO:0060298),1/14,0.011145440218903,0.0529076577039536,0,0,102.4153846153846,460.53380130419424,NRG1
454,GO_Biological_Process_2017b,regulation of protein autoubiquitination (GO:1902498),1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,PRKN
455,GO_Biological_Process_2017b,membrane repolarization during AV node cell action potential (GO:0086049),1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,KCND3
456,GO_Biological_Process_2017b,ubiquitin-dependent protein catabolic process via the N-end rule pathway (GO:0071596),2/195,0.0103735537446033,0.0529076577039536,0,0,14.649148778682456,66.92457204228684,PRKN;BTBD9
457,GO_Biological_Process_2017b,ubiquitin-dependent catabolism of misfolded proteins by cytoplasm-associated proteasome (GO:0071629),2/198,0.0106811271691611,0.0529076577039536,0,0,14.42274052478134,65.46881305511042,PRKN;BTBD9
458,GO_Biological_Process_2017b,ubiquitin-dependent catabolism of misfolded proteins by nucleus-associated proteasome (GO:0071630),2/200,0.0108884250018907,0.0529076577039536,0,0,14.275613275613276,64.52655688502057,PRKN;BTBD9
459,GO_Biological_Process_2017b,anaphase-promoting complex-dependent catabolic process (GO:0031145),2/201,0.0109927465095029,0.0529076577039536,0,0,14.203158650394831,64.06362592782344,PRKN;BTBD9
460,GO_Biological_Process_2017b,regulation of mitochondrial fusion (GO:0010635),1/14,0.011145440218903,0.0529076577039536,0,0,102.4153846153846,460.53380130419424,PRKN
461,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to hydrostatic pressure (GO:0061405),1/14,0.011145440218903,0.0529076577039536,0,0,102.4153846153846,460.53380130419424,SMAD9
462,GO_Biological_Process_2017b,dopamine catabolic process (GO:0042420),1/14,0.011145440218903,0.0529076577039536,0,0,102.4153846153846,460.53380130419424,PRKN
463,GO_Biological_Process_2017b,negative regulation of removal of superoxide radicals (GO:1904832),1/14,0.011145440218903,0.0529076577039536,0,0,102.4153846153846,460.53380130419424,PRKN
464,GO_Biological_Process_2017b,cellular response to dopamine (GO:1903351),1/14,0.011145440218903,0.0529076577039536,0,0,102.4153846153846,460.53380130419424,PRKN
465,GO_Biological_Process_2017b,negative regulation of mitochondrion organization (GO:0010823),1/14,0.011145440218903,0.0529076577039536,0,0,102.4153846153846,460.53380130419424,PRKN
466,GO_Biological_Process_2017b,negative regulation of ERBB3 signaling pathway (GO:1905579),1/14,0.011145440218903,0.0529076577039536,0,0,102.4153846153846,460.53380130419424,NRG1
467,GO_Biological_Process_2017b,regulation of dopamine secretion (GO:0014059),1/14,0.011145440218903,0.0529076577039536,0,0,102.4153846153846,460.53380130419424,PRKN
468,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance (GO:0061395),1/14,0.011145440218903,0.0529076577039536,0,0,102.4153846153846,460.53380130419424,SMAD9
469,GO_Biological_Process_2017b,regulation of nitric oxide metabolic process (GO:0080164),1/14,0.011145440218903,0.0529076577039536,0,0,102.4153846153846,460.53380130419424,PRKN
470,GO_Biological_Process_2017b,regulation of histone ubiquitination (GO:0033182),1/14,0.011145440218903,0.0529076577039536,0,0,102.4153846153846,460.53380130419424,PRKN
452,GO_Biological_Process_2017b,regulation of release of cytochrome c from mitochondria (GO:0090199),1/13,0.0103532125188836,0.0529076577039536,0,0,110.95555555555556,507.11775303850175,PRKN
411,GO_Biological_Process_2017b,His-Purkinje system cell differentiation (GO:0060932),1/11,0.0087669723009575,0.0529076577039536,0,0,133.16,630.7474630602054,NRG1
410,GO_Biological_Process_2017b,negative stranded viral RNA replication (GO:0039689),1/11,0.0087669723009575,0.0529076577039536,0,0,133.16,630.7474630602054,ATG16L1
409,GO_Biological_Process_2017b,cardiac pacemaker cell differentiation (GO:0060920),1/11,0.0087669723009575,0.0529076577039536,0,0,133.16,630.7474630602054,NRG1
351,GO_Biological_Process_2017b,regulation of fatty acid transport (GO:2000191),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,PRKN
352,GO_Biological_Process_2017b,negative regulation of testosterone secretion (GO:2000844),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,NRG1
353,GO_Biological_Process_2017b,negative regulation of renal sodium excretion (GO:0035814),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,NRG1
354,GO_Biological_Process_2017b,carbon catabolite activation of transcription from RNA polymerase II promoter (GO:0000436),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,SMAD9
355,GO_Biological_Process_2017b,cellular polysaccharide biosynthetic process (GO:0033692),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,EXT1
356,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to maltose (GO:1904765),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,SMAD9
357,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to methylglyoxal (GO:0097239),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,SMAD9
350,GO_Biological_Process_2017b,negative regulation of estradiol secretion (GO:2000865),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,NRG1
358,GO_Biological_Process_2017b,positive regulation of mitochondrial fusion (GO:0010636),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,PRKN
360,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to copper ion (GO:0061397),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,SMAD9
361,GO_Biological_Process_2017b,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,PRKN
362,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter by pheromones (GO:0007329),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,SMAD9
363,GO_Biological_Process_2017b,negative regulation of androstenedione secretion (GO:2000838),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,NRG1
364,GO_Biological_Process_2017b,negative regulation of estrone secretion (GO:2000868),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,NRG1
365,GO_Biological_Process_2017b,negative regulation of mitochondrial fusion (GO:0010637),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,PRKN
366,GO_Biological_Process_2017b,regulation of removal of superoxide radicals (GO:2000121),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,PRKN
359,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to iron (GO:0010723),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,SMAD9
349,GO_Biological_Process_2017b,negative regulation of exosomal secretion (GO:1903542),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,PRKN
348,GO_Biological_Process_2017b,negative regulation of dehydroepiandrosterone secretion (GO:2000841),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,NRG1
347,GO_Biological_Process_2017b,regulation of protein import into mitochondrial outer membrane (GO:1903636),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,PRKN
330,GO_Biological_Process_2017b,positive regulation of protein import into mitochondrial outer membrane (GO:1903638),2/89,0.0022562411326776,0.0529076577039536,0,0,32.67159277504105,199.10248546522357,PRKN;NRG1
331,GO_Biological_Process_2017b,macroautophagy (GO:0016236),2/91,0.0023571766245942,0.0529076577039536,0,0,31.93418940609952,193.21112986707715,PRKN;ATG16L1
332,GO_Biological_Process_2017b,selective autophagy (GO:0061912),2/91,0.0023571766245942,0.0529076577039536,0,0,31.93418940609952,193.21112986707715,PRKN;ATG16L1
333,GO_Biological_Process_2017b,autophagosome organization (GO:1905037),2/93,0.0024602226064317,0.0529076577039536,0,0,31.22919937205652,187.60952274078335,PRKN;ATG16L1
334,GO_Biological_Process_2017b,autophagosome maturation (GO:0097352),2/103,0.003006895093628,0.0529076577039536,0,0,28.123055162659124,163.30628589767113,PRKN;ATG16L1
335,GO_Biological_Process_2017b,positive regulation of protein targeting to mitochondrion (GO:1903955),2/113,0.0036054127233747,0.0529076577039536,0,0,25.576576576576574,143.876402898192,PRKN;NRG1
336,GO_Biological_Process_2017b,regulation of cellular response to oxidative stress (GO:1900407),1/6,0.0047909422750142,0.0529076577039536,0,0,266.38666666666666,1422.7786907214238,PRKN
337,GO_Biological_Process_2017b,negative regulation of gastric acid secretion (GO:0060455),1/6,0.0047909422750142,0.0529076577039536,0,0,266.38666666666666,1422.7786907214238,NRG1
338,GO_Biological_Process_2017b,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:0061734),1/6,0.0047909422750142,0.0529076577039536,0,0,266.38666666666666,1422.7786907214238,PRKN
339,GO_Biological_Process_2017b,cellular response to manganese ion (GO:0071287),1/6,0.0047909422750142,0.0529076577039536,0,0,266.38666666666666,1422.7786907214238,PRKN
340,GO_Biological_Process_2017b,regulation of phospholipid transport (GO:2001138),1/6,0.0047909422750142,0.0529076577039536,0,0,266.38666666666666,1422.7786907214238,PRKN
341,GO_Biological_Process_2017b,negative regulation of actin filament bundle assembly (GO:0032232),1/6,0.0047909422750142,0.0529076577039536,0,0,266.38666666666666,1422.7786907214238,PRKN
342,GO_Biological_Process_2017b,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902239),1/6,0.0047909422750142,0.0529076577039536,0,0,266.38666666666666,1422.7786907214238,PRKN
343,GO_Biological_Process_2017b,mitochondrial unfolded protein response (GO:0034514),1/6,0.0047909422750142,0.0529076577039536,0,0,266.38666666666666,1422.7786907214238,PRKN
344,GO_Biological_Process_2017b,amphisome-lysosome fusion (GO:0061911),2/138,0.0053235834718738,0.0529076577039536,0,0,20.84873949579832,109.15584016709676,PRKN;ATG16L1
345,GO_Biological_Process_2017b,autophagosome-endosome fusion (GO:0061910),2/138,0.0053235834718738,0.0529076577039536,0,0,20.84873949579832,109.15584016709676,PRKN;ATG16L1
346,GO_Biological_Process_2017b,autophagosome-lysosome fusion (GO:0061909),2/138,0.0053235834718738,0.0529076577039536,0,0,20.84873949579832,109.15584016709676,PRKN;ATG16L1
367,GO_Biological_Process_2017b,"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,EXT1
368,GO_Biological_Process_2017b,dopamine metabolic process (GO:0042417),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,PRKN
369,GO_Biological_Process_2017b,negative regulation of primary amine oxidase activity (GO:1902283),1/7,0.0055873417078214,0.0529076577039536,0,0,221.9777777777778,1151.4545938502376,PRKN
370,GO_Biological_Process_2017b,negative regulation of saliva secretion (GO:1905747),1/8,0.0063831440708516,0.0529076577039536,0,0,190.25714285714287,961.5775796687342,NRG1
392,GO_Biological_Process_2017b,"regulation of synaptic transmission, glycinergic (GO:0060092)",1/10,0.0079729589968486,0.0529076577039536,0,0,147.96296296296296,714.9125872208035,BTBD9
393,GO_Biological_Process_2017b,regulation of neuromuscular synaptic transmission (GO:1900073),1/10,0.0079729589968486,0.0529076577039536,0,0,147.96296296296296,714.9125872208035,BTBD9
394,GO_Biological_Process_2017b,negative regulation of nitric oxide metabolic process (GO:1904406),1/10,0.0079729589968486,0.0529076577039536,0,0,147.96296296296296,714.9125872208035,PRKN
395,GO_Biological_Process_2017b,thelarche (GO:0042695),1/10,0.0079729589968486,0.0529076577039536,0,0,147.96296296296296,714.9125872208035,NRG1
396,GO_Biological_Process_2017b,right ventricular trabecular myocardium morphogenesis (GO:0003227),1/10,0.0079729589968486,0.0529076577039536,0,0,147.96296296296296,714.9125872208035,NRG1
397,GO_Biological_Process_2017b,mammary gland development (GO:0030879),1/10,0.0079729589968486,0.0529076577039536,0,0,147.96296296296296,714.9125872208035,NRG1
398,GO_Biological_Process_2017b,modulation by symbiont of host synaptic transmission (GO:0044758),1/10,0.0079729589968486,0.0529076577039536,0,0,147.96296296296296,714.9125872208035,BTBD9
399,GO_Biological_Process_2017b,modulation of chemical synaptic transmission (GO:0050804),1/10,0.0079729589968486,0.0529076577039536,0,0,147.96296296296296,714.9125872208035,BTBD9
400,GO_Biological_Process_2017b,"trans-synaptic signaling, modulating synaptic transmission (GO:0099550)",1/10,0.0079729589968486,0.0529076577039536,0,0,147.96296296296296,714.9125872208035,BTBD9
401,GO_Biological_Process_2017b,"regulation of modification of synapse structure, modulating synaptic transmission (GO:0098987)",1/10,0.0079729589968486,0.0529076577039536,0,0,147.96296296296296,714.9125872208035,BTBD9
402,GO_Biological_Process_2017b,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),1/10,0.0079729589968486,0.0529076577039536,0,0,147.96296296296296,714.9125872208035,BTBD9
403,GO_Biological_Process_2017b,rhythmic synaptic transmission (GO:0060024),1/11,0.0087669723009575,0.0529076577039536,0,0,133.16,630.7474630602054,BTBD9
404,GO_Biological_Process_2017b,atrial cardiac muscle cell differentiation (GO:0055011),1/11,0.0087669723009575,0.0529076577039536,0,0,133.16,630.7474630602054,NRG1
405,GO_Biological_Process_2017b,cardiac neural crest cell development involved in heart development (GO:0061308),1/11,0.0087669723009575,0.0529076577039536,0,0,133.16,630.7474630602054,NRG1
406,GO_Biological_Process_2017b,regulation of glucokinase activity (GO:0033131),1/11,0.0087669723009575,0.0529076577039536,0,0,133.16,630.7474630602054,PRKN
407,GO_Biological_Process_2017b,positive regulation of myotube differentiation (GO:0010831),1/11,0.0087669723009575,0.0529076577039536,0,0,133.16,630.7474630602054,NRG1
408,GO_Biological_Process_2017b,negative regulation of superoxide anion generation (GO:0032929),1/11,0.0087669723009575,0.0529076577039536,0,0,133.16,630.7474630602054,PRKN
391,GO_Biological_Process_2017b,"regulation of synaptic transmission, cholinergic (GO:0032222)",1/10,0.0079729589968486,0.0529076577039536,0,0,147.96296296296296,714.9125872208035,BTBD9
491,GO_Biological_Process_2017b,positive regulation of triplex DNA binding (GO:1905498),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PRKN
390,GO_Biological_Process_2017b,"modification of synaptic structure, modulating synaptic transmission (GO:0099564)",1/10,0.0079729589968486,0.0529076577039536,0,0,147.96296296296296,714.9125872208035,BTBD9
388,GO_Biological_Process_2017b,left ventricular trabecular myocardium morphogenesis (GO:0003225),1/10,0.0079729589968486,0.0529076577039536,0,0,147.96296296296296,714.9125872208035,NRG1
371,GO_Biological_Process_2017b,positive regulation of cardiac muscle cell differentiation (GO:2000727),1/8,0.0063831440708516,0.0529076577039536,0,0,190.25714285714287,961.5775796687342,NRG1
372,GO_Biological_Process_2017b,negative regulation of secretion (GO:0051048),1/8,0.0063831440708516,0.0529076577039536,0,0,190.25714285714287,961.5775796687342,NRG1
373,GO_Biological_Process_2017b,poly-N-acetyllactosamine biosynthetic process (GO:0030311),1/8,0.0063831440708516,0.0529076577039536,0,0,190.25714285714287,961.5775796687342,EXT1
374,GO_Biological_Process_2017b,6-alpha-maltosylglucose biosynthetic process (GO:0051680),1/8,0.0063831440708516,0.0529076577039536,0,0,190.25714285714287,961.5775796687342,EXT1
375,GO_Biological_Process_2017b,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903384),1/8,0.0063831440708516,0.0529076577039536,0,0,190.25714285714287,961.5775796687342,PRKN
376,GO_Biological_Process_2017b,positive regulation of synaptic vesicle transport (GO:1902805),1/8,0.0063831440708516,0.0529076577039536,0,0,190.25714285714287,961.5775796687342,PRKN
377,GO_Biological_Process_2017b,central nervous system neuron differentiation (GO:0021953),2/159,0.0070051145147265,0.0529076577039536,0,0,18.040946314831665,89.50320489816689,PRKN;PTPRD
378,GO_Biological_Process_2017b,potassium ion export (GO:0071435),1/9,0.007178349711373,0.0529076577039536,0,0,166.46666666666667,821.7936241053455,KCND3
379,GO_Biological_Process_2017b,cardiac muscle cell membrane repolarization (GO:0099622),1/9,0.007178349711373,0.0529076577039536,0,0,166.46666666666667,821.7936241053455,KCND3
380,GO_Biological_Process_2017b,potassium ion export from cell (GO:0098668),1/9,0.007178349711373,0.0529076577039536,0,0,166.46666666666667,821.7936241053455,KCND3
381,GO_Biological_Process_2017b,regulation of oxidative stress-induced cell death (GO:1903201),1/9,0.007178349711373,0.0529076577039536,0,0,166.46666666666667,821.7936241053455,PRKN
382,GO_Biological_Process_2017b,positive regulation of SREBP signaling pathway in response to decreased oxygen levels (GO:0038176),1/9,0.007178349711373,0.0529076577039536,0,0,166.46666666666667,821.7936241053455,SMAD9
383,GO_Biological_Process_2017b,membrane repolarization during Purkinje myocyte action potential (GO:0086051),1/9,0.007178349711373,0.0529076577039536,0,0,166.46666666666667,821.7936241053455,KCND3
384,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to cobalt ion (GO:0061399),1/9,0.007178349711373,0.0529076577039536,0,0,166.46666666666667,821.7936241053455,SMAD9
385,GO_Biological_Process_2017b,"chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0050653)",1/9,0.007178349711373,0.0529076577039536,0,0,166.46666666666667,821.7936241053455,EXT1
386,GO_Biological_Process_2017b,negative regulation of lipid transport (GO:0032369),1/9,0.007178349711373,0.0529076577039536,0,0,166.46666666666667,821.7936241053455,PRKN
387,GO_Biological_Process_2017b,regulation of peptidyl-tyrosine autophosphorylation (GO:1900084),1/9,0.007178349711373,0.0529076577039536,0,0,166.46666666666667,821.7936241053455,MOB1B
389,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to ethanol (GO:0061410),1/10,0.0079729589968486,0.0529076577039536,0,0,147.96296296296296,714.9125872208035,SMAD9
492,GO_Biological_Process_2017b,1-deoxy-D-xylulose 5-phosphate metabolic process (GO:0052863),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
329,GO_Biological_Process_2017b,positive regulation of protein homodimerization activity (GO:0090073),2/51,0.0007477269425466376,0.0529076577039536,0,0,58.1195335276968,418.3718752445384,PRKN;NRG1
494,GO_Biological_Process_2017b,negative regulation of dopamine secretion (GO:0033602),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PRKN
328,GO_Biological_Process_2017b,negative regulation of protein autophosphorylation (GO:0031953),2/50,0.0007187392304892979,0.0529076577039536,0,0,59.333333333333336,429.45537567816734,PRKN;MOB1B
524,GO_Biological_Process_2017b,mammary gland fat development (GO:0060611),1/17,0.0135185584535393,0.0529076577039536,0,0,83.2,358.0671608642671,NRG1
523,GO_Biological_Process_2017b,positive regulation of telomeric DNA binding (GO:1904744),1/17,0.0135185584535393,0.0529076577039536,0,0,83.2,358.0671608642671,PRKN
522,GO_Biological_Process_2017b,L-methionine biosynthetic process from O-phospho-L-homoserine and cystathionine (GO:0019283),1/17,0.0135185584535393,0.0529076577039536,0,0,83.2,358.0671608642671,PTPRD
521,GO_Biological_Process_2017b,molybdopterin cofactor metabolic process (GO:0043545),1/17,0.0135185584535393,0.0529076577039536,0,0,83.2,358.0671608642671,PTPRD
520,GO_Biological_Process_2017b,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),1/17,0.0135185584535393,0.0529076577039536,0,0,83.2,358.0671608642671,PRKN
519,GO_Biological_Process_2017b,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),1/17,0.0135185584535393,0.0529076577039536,0,0,83.2,358.0671608642671,PRKN
518,GO_Biological_Process_2017b,regulation of protein heterodimerization activity (GO:0043497),1/17,0.0135185584535393,0.0529076577039536,0,0,83.2,358.0671608642671,NRG1
517,GO_Biological_Process_2017b,regulation of hydrogen peroxide metabolic process (GO:0010310),1/17,0.0135185584535393,0.0529076577039536,0,0,83.2,358.0671608642671,PRKN
516,GO_Biological_Process_2017b,lipid X metabolic process (GO:2001289),1/17,0.0135185584535393,0.0529076577039536,0,0,83.2,358.0671608642671,PTPRD
515,GO_Biological_Process_2017b,mammary gland epithelium development (GO:0061180),1/17,0.0135185584535393,0.0529076577039536,0,0,83.2,358.0671608642671,NRG1
514,GO_Biological_Process_2017b,protein localization to cytosolic proteasome complex involved in ERAD pathway (GO:1904379),1/17,0.0135185584535393,0.0529076577039536,0,0,83.2,358.0671608642671,PRKN
513,GO_Biological_Process_2017b,cellular zinc ion homeostasis (GO:0006882),1/17,0.0135185584535393,0.0529076577039536,0,0,83.2,358.0671608642671,PRKN
511,GO_Biological_Process_2017b,phosphagen metabolic process (GO:0006599),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
510,GO_Biological_Process_2017b,carbamoyl phosphate metabolic process (GO:0070408),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
512,GO_Biological_Process_2017b,thiamine diphosphate metabolic process (GO:0042357),1/17,0.0135185584535393,0.0529076577039536,0,0,83.2,358.0671608642671,PTPRD
508,GO_Biological_Process_2017b,O3-(N-acetylglucosamine-1-phosphoryl)-L-serine biosynthetic process (GO:0018425),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
495,GO_Biological_Process_2017b,regulation of protein homodimerization activity (GO:0043496),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,NRG1
496,GO_Biological_Process_2017b,free ubiquitin chain polymerization (GO:0010994),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PRKN
497,GO_Biological_Process_2017b,methanopterin-containing compound metabolic process (GO:2001115),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
498,GO_Biological_Process_2017b,alditol phosphate metabolic process (GO:0052646),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
499,GO_Biological_Process_2017b,dopamine biosynthetic process (GO:0042416),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PRKN
509,GO_Biological_Process_2017b,regulation of protein targeting to mitochondrion (GO:1903214),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PRKN
501,GO_Biological_Process_2017b,ribose phosphate metabolic process (GO:0019693),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
500,GO_Biological_Process_2017b,presynaptic membrane assembly (GO:0097105),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
503,GO_Biological_Process_2017b,deoxyribose phosphate metabolic process (GO:0019692),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
504,GO_Biological_Process_2017b,D-glycero-D-manno-heptose 7-phosphate metabolic process (GO:2001060),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
505,GO_Biological_Process_2017b,"cyclic 2,3-bisphospho-D-glycerate biosynthetic process (GO:1901369)",1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
506,GO_Biological_Process_2017b,glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
507,GO_Biological_Process_2017b,6-sulfoquinovose(1-) catabolic process to glycerone phosphate and 3-sulfolactaldehyde (GO:0061720),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PTPRD
502,GO_Biological_Process_2017b,positive regulation of recombination hotspot binding (GO:1903643),1/16,0.0127281127836324,0.0529076577039536,0,0,88.75111111111111,387.3047125888365,PRKN
532,GO_Biological_Process_2017b,maintenance of unfolded protein involved in ERAD pathway (GO:1904378),1/18,0.0143084109196949,0.0530374270148309,0,0,78.30196078431372,332.5412031884909,PRKN
535,GO_Biological_Process_2017b,cardiac muscle cell fate commitment (GO:0060923),1/18,0.0143084109196949,0.0530374270148309,0,0,78.30196078431372,332.5412031884909,NRG1
534,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway involved in heart development (GO:1905066),1/18,0.0143084109196949,0.0530374270148309,0,0,78.30196078431372,332.5412031884909,PRKN
533,GO_Biological_Process_2017b,regulation of ubiquitin-protein transferase activity (GO:0051438),1/18,0.0143084109196949,0.0530374270148309,0,0,78.30196078431372,332.5412031884909,PRKN
531,GO_Biological_Process_2017b,"7,8-dihydroneopterin 3'-triphosphate biosynthetic process (GO:0035998)",1/18,0.0143084109196949,0.0530374270148309,0,0,78.30196078431372,332.5412031884909,PTPRD
529,GO_Biological_Process_2017b,"fructose 2,6-bisphosphate metabolic process (GO:0006003)",1/18,0.0143084109196949,0.0530374270148309,0,0,78.30196078431372,332.5412031884909,PTPRD
528,GO_Biological_Process_2017b,regulation of heart induction by regulation of canonical Wnt signaling pathway (GO:0090081),1/18,0.0143084109196949,0.0530374270148309,0,0,78.30196078431372,332.5412031884909,PRKN
527,GO_Biological_Process_2017b,regulation of mitochondrial fission (GO:0090140),1/18,0.0143084109196949,0.0530374270148309,0,0,78.30196078431372,332.5412031884909,PRKN
526,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway involved in neural crest cell differentiation (GO:0072335),1/18,0.0143084109196949,0.0530374270148309,0,0,78.30196078431372,332.5412031884909,PRKN
525,GO_Biological_Process_2017b,positive regulation of glucose metabolic process (GO:0010907),1/18,0.0143084109196949,0.0530374270148309,0,0,78.30196078431372,332.5412031884909,PRKN
530,GO_Biological_Process_2017b,positive regulation of DNA replication origin binding (GO:1902597),1/18,0.0143084109196949,0.0530374270148309,0,0,78.30196078431372,332.5412031884909,PRKN
32,GO_Biological_Process_2018,cellular response to dopamine (GO:1903351),1/9,0.007178349711373,0.0530636814641577,0,0,166.46666666666667,821.7936241053455,PRKN
43,GO_Biological_Process_2018,modulation by virus of host process (GO:0019054),1/13,0.0103532125188836,0.0530636814641577,0,0,110.95555555555556,507.11775303850175,PRKN
42,GO_Biological_Process_2018,viral RNA genome replication (GO:0039694),1/12,0.0095603900128118,0.0530636814641577,0,0,121.04848484848485,562.8907982194623,ATG16L1
41,GO_Biological_Process_2018,negative regulation of oxidoreductase activity (GO:0051354),1/12,0.0095603900128118,0.0530636814641577,0,0,121.04848484848485,562.8907982194623,PRKN
40,GO_Biological_Process_2018,membrane repolarization during action potential (GO:0086011),1/11,0.0087669723009575,0.0530636814641577,0,0,133.16,630.7474630602054,KCND3
37,GO_Biological_Process_2018,presynaptic membrane organization (GO:0097090),1/11,0.0087669723009575,0.0530636814641577,0,0,133.16,630.7474630602054,PTPRD
38,GO_Biological_Process_2018,modulation by host of viral genome replication (GO:0044827),1/11,0.0087669723009575,0.0530636814641577,0,0,133.16,630.7474630602054,PRKN
36,GO_Biological_Process_2018,presynaptic membrane assembly (GO:0097105),1/10,0.0079729589968486,0.0530636814641577,0,0,147.96296296296296,714.9125872208035,PTPRD
35,GO_Biological_Process_2018,negative regulation by host of viral process (GO:0044793),1/10,0.0079729589968486,0.0530636814641577,0,0,147.96296296296296,714.9125872208035,PRKN
34,GO_Biological_Process_2018,positive regulation of cytoplasmic transport (GO:1903651),1/10,0.0079729589968486,0.0530636814641577,0,0,147.96296296296296,714.9125872208035,PRKN
33,GO_Biological_Process_2018,negative regulation of oxidative stress-induced neuron death (GO:1903204),1/10,0.0079729589968486,0.0530636814641577,0,0,147.96296296296296,714.9125872208035,PRKN
39,GO_Biological_Process_2018,cardiac muscle cell membrane repolarization (GO:0099622),1/11,0.0087669723009575,0.0530636814641577,0,0,133.16,630.7474630602054,KCND3
44,GO_Biological_Process_2018,regulation of synaptic vesicle transport (GO:1902803),1/13,0.0103532125188836,0.0530636814641577,0,0,110.95555555555556,507.11775303850175,PRKN
46,GO_Biological_Process_2018,regulation of cellular carbohydrate metabolic process (GO:0010675),1/13,0.0103532125188836,0.0530636814641577,0,0,110.95555555555556,507.11775303850175,PRKN
47,GO_Biological_Process_2018,membrane repolarization (GO:0086009),1/13,0.0103532125188836,0.0530636814641577,0,0,110.95555555555556,507.11775303850175,KCND3
48,GO_Biological_Process_2018,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),1/14,0.011145440218903,0.0530636814641577,0,0,102.4153846153846,460.53380130419424,PRKN
49,GO_Biological_Process_2018,positive regulation of mitochondrial fission (GO:0090141),1/14,0.011145440218903,0.0530636814641577,0,0,102.4153846153846,460.53380130419424,PRKN
50,GO_Biological_Process_2018,stem cell development (GO:0048864),1/14,0.011145440218903,0.0530636814641577,0,0,102.4153846153846,460.53380130419424,NRG1
51,GO_Biological_Process_2018,regulation of protein modification by small protein conjugation or removal (GO:1903320),1/14,0.011145440218903,0.0530636814641577,0,0,102.4153846153846,460.53380130419424,PRKN
52,GO_Biological_Process_2018,regulation of secretion (GO:0051046),1/14,0.011145440218903,0.0530636814641577,0,0,102.4153846153846,460.53380130419424,NRG1
53,GO_Biological_Process_2018,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),1/14,0.011145440218903,0.0530636814641577,0,0,102.4153846153846,460.53380130419424,PRKN
54,GO_Biological_Process_2018,negative regulation of secretion (GO:0051048),1/14,0.011145440218903,0.0530636814641577,0,0,102.4153846153846,460.53380130419424,NRG1
55,GO_Biological_Process_2018,neural crest cell differentiation (GO:0014033),1/15,0.0119370735063595,0.0530636814641577,0,0,95.0952380952381,421.0918230074216,NRG1
56,GO_Biological_Process_2018,cardiac muscle cell differentiation (GO:0055007),1/15,0.0119370735063595,0.0530636814641577,0,0,95.0952380952381,421.0918230074216,NRG1
57,GO_Biological_Process_2018,membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/15,0.0119370735063595,0.0530636814641577,0,0,95.0952380952381,421.0918230074216,KCND3
58,GO_Biological_Process_2018,mesenchymal cell development (GO:0014031),1/15,0.0119370735063595,0.0530636814641577,0,0,95.0952380952381,421.0918230074216,NRG1
45,GO_Biological_Process_2018,cardiocyte differentiation (GO:0035051),1/13,0.0103532125188836,0.0530636814641577,0,0,110.95555555555556,507.11775303850175,NRG1
31,GO_Biological_Process_2018,potassium ion export (GO:0071435),1/9,0.007178349711373,0.0530636814641577,0,0,166.46666666666667,821.7936241053455,KCND3
10,GO_Biological_Process_2018,"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",1/6,0.0047909422750142,0.0530636814641577,0,0,266.38666666666666,1422.7786907214238,EXT1
29,GO_Biological_Process_2018,regulation of oxidative stress-induced cell death (GO:1903201),1/9,0.007178349711373,0.0530636814641577,0,0,166.46666666666667,821.7936241053455,PRKN
1,GO_Biological_Process_2018,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),2/70,0.0014037974466504,0.0530636814641577,0,0,41.84033613445378,274.8313546509682,PRKN;BTBD9
2,GO_Biological_Process_2018,regulation of protein targeting to mitochondrion (GO:1903214),2/88,0.002206566745469,0.0530636814641577,0,0,33.053156146179404,202.16359671384905,PRKN;NRG1
3,GO_Biological_Process_2018,macroautophagy (GO:0016236),2/110,0.0034204588487804,0.0530636814641577,0,0,26.29100529100529,149.27981722379184,PRKN;ATG16L1
4,GO_Biological_Process_2018,regulation of protein binding (GO:0043393),2/111,0.0034815980040795,0.0530636814641577,0,0,26.04849279161206,147.44134324199263,PRKN;NRG1
5,GO_Biological_Process_2018,positive regulation of mitochondrion organization (GO:0010822),2/128,0.0045987461135236,0.0530636814641577,0,0,22.514739229024944,121.1736870368518,PRKN;NRG1
6,GO_Biological_Process_2018,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),1/6,0.0047909422750142,0.0530636814641577,0,0,266.38666666666666,1422.7786907214238,PRKN
7,GO_Biological_Process_2018,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),1/6,0.0047909422750142,0.0530636814641577,0,0,266.38666666666666,1422.7786907214238,NRG1
8,GO_Biological_Process_2018,regulation of dopamine metabolic process (GO:0042053),1/6,0.0047909422750142,0.0530636814641577,0,0,266.38666666666666,1422.7786907214238,PRKN
9,GO_Biological_Process_2018,positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),1/6,0.0047909422750142,0.0530636814641577,0,0,266.38666666666666,1422.7786907214238,PRKN
59,GO_Biological_Process_2018,catecholamine metabolic process (GO:0006584),1/15,0.0119370735063595,0.0530636814641577,0,0,95.0952380952381,421.0918230074216,PRKN
11,GO_Biological_Process_2018,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),1/6,0.0047909422750142,0.0530636814641577,0,0,266.38666666666666,1422.7786907214238,PTPRD
12,GO_Biological_Process_2018,response to manganese ion (GO:0010042),1/6,0.0047909422750142,0.0530636814641577,0,0,266.38666666666666,1422.7786907214238,PRKN
13,GO_Biological_Process_2018,regulation of glucokinase activity (GO:0033131),1/6,0.0047909422750142,0.0530636814641577,0,0,266.38666666666666,1422.7786907214238,PRKN
30,GO_Biological_Process_2018,response to dopamine (GO:1903350),1/9,0.007178349711373,0.0530636814641577,0,0,166.46666666666667,821.7936241053455,PRKN
14,GO_Biological_Process_2018,regulation of cellular response to oxidative stress (GO:1900407),1/6,0.0047909422750142,0.0530636814641577,0,0,266.38666666666666,1422.7786907214238,PRKN
16,GO_Biological_Process_2018,regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),1/6,0.0047909422750142,0.0530636814641577,0,0,266.38666666666666,1422.7786907214238,PRKN
17,GO_Biological_Process_2018,regulation of protein heterodimerization activity (GO:0043497),1/7,0.0055873417078214,0.0530636814641577,0,0,221.9777777777778,1151.4545938502376,NRG1
18,GO_Biological_Process_2018,positive regulation of autophagy of mitochondrion (GO:1903599),1/7,0.0055873417078214,0.0530636814641577,0,0,221.9777777777778,1151.4545938502376,PRKN
19,GO_Biological_Process_2018,positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),1/7,0.0055873417078214,0.0530636814641577,0,0,221.9777777777778,1151.4545938502376,PRKN
20,GO_Biological_Process_2018,regulation of mitochondrial fusion (GO:0010635),1/7,0.0055873417078214,0.0530636814641577,0,0,221.9777777777778,1151.4545938502376,PRKN
21,GO_Biological_Process_2018,regulation of establishment of protein localization to mitochondrion (GO:1903747),1/8,0.0063831440708516,0.0530636814641577,0,0,190.25714285714287,961.5775796687342,PRKN
22,GO_Biological_Process_2018,regulation of lipid transport (GO:0032368),1/8,0.0063831440708516,0.0530636814641577,0,0,190.25714285714287,961.5775796687342,PRKN
23,GO_Biological_Process_2018,protein K6-linked ubiquitination (GO:0085020),1/8,0.0063831440708516,0.0530636814641577,0,0,190.25714285714287,961.5775796687342,PRKN
24,GO_Biological_Process_2018,regulation of striated muscle cell differentiation (GO:0051153),1/8,0.0063831440708516,0.0530636814641577,0,0,190.25714285714287,961.5775796687342,NRG1
25,GO_Biological_Process_2018,regulation of response to oxidative stress (GO:1902882),1/8,0.0063831440708516,0.0530636814641577,0,0,190.25714285714287,961.5775796687342,PRKN
26,GO_Biological_Process_2018,ventricular cardiac muscle cell membrane repolarization (GO:0099625),1/8,0.0063831440708516,0.0530636814641577,0,0,190.25714285714287,961.5775796687342,KCND3
27,GO_Biological_Process_2018,ventricular trabecula myocardium morphogenesis (GO:0003222),1/8,0.0063831440708516,0.0530636814641577,0,0,190.25714285714287,961.5775796687342,NRG1
28,GO_Biological_Process_2018,negative regulation of exocytosis (GO:0045920),1/8,0.0063831440708516,0.0530636814641577,0,0,190.25714285714287,961.5775796687342,PRKN
15,GO_Biological_Process_2018,regulation of protein targeting (GO:1903533),1/6,0.0047909422750142,0.0530636814641577,0,0,266.38666666666666,1422.7786907214238,PRKN
60,GO_Biological_Process_2018,negative regulation of release of cytochrome c from mitochondria (GO:0090201),1/15,0.0119370735063595,0.0530636814641577,0,0,95.0952380952381,421.0918230074216,PRKN
0,GO_Biological_Process_2018,negative regulation of transport (GO:0051051),2/40,0.0004597842333580924,0.0530636814641577,0,0,74.98496240601504,576.2409325339859,PRKN;NRG1
62,GO_Biological_Process_2018,heparan sulfate proteoglycan biosynthetic process (GO:0015012),1/15,0.0119370735063595,0.0530636814641577,0,0,95.0952380952381,421.0918230074216,EXT1
63,GO_Biological_Process_2018,negative regulation of insulin secretion (GO:0046676),1/15,0.0119370735063595,0.0530636814641577,0,0,95.0952380952381,421.0918230074216,PRKN
64,GO_Biological_Process_2018,negative regulation of signal transduction by p53 class mediator (GO:1901797),1/15,0.0119370735063595,0.0530636814641577,0,0,95.0952380952381,421.0918230074216,PRKN
65,GO_Biological_Process_2018,regulation of protein homodimerization activity (GO:0043496),1/16,0.0127281127836324,0.0530636814641577,0,0,88.75111111111111,387.3047125888365,NRG1
66,GO_Biological_Process_2018,regulation of exosomal secretion (GO:1903541),1/16,0.0127281127836324,0.0530636814641577,0,0,88.75111111111111,387.3047125888365,PRKN
67,GO_Biological_Process_2018,positive regulation of dendrite morphogenesis (GO:0050775),1/16,0.0127281127836324,0.0530636814641577,0,0,88.75111111111111,387.3047125888365,PTPRD
68,GO_Biological_Process_2018,regulation of dopamine secretion (GO:0014059),1/16,0.0127281127836324,0.0530636814641577,0,0,88.75111111111111,387.3047125888365,PRKN
69,GO_Biological_Process_2018,negative regulation of peptide hormone secretion (GO:0090278),1/16,0.0127281127836324,0.0530636814641577,0,0,88.75111111111111,387.3047125888365,PRKN
70,GO_Biological_Process_2018,myoblast differentiation (GO:0045445),1/16,0.0127281127836324,0.0530636814641577,0,0,88.75111111111111,387.3047125888365,NRG1
61,GO_Biological_Process_2018,presynapse assembly (GO:0099054),1/15,0.0119370735063595,0.0530636814641577,0,0,95.0952380952381,421.0918230074216,PTPRD
91,GO_Biological_Process_2018,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),1/22,0.0174618968734111,0.0536608285428013,0,0,63.37460317460317,256.52354192445085,PRKN
92,GO_Biological_Process_2018,protein O-linked glycosylation via serine (GO:0018242),1/22,0.0174618968734111,0.0536608285428013,0,0,63.37460317460317,256.52354192445085,GALNTL6
94,GO_Biological_Process_2018,regulation of protein phosphorylation (GO:0001932),2/261,0.0180464894366593,0.0536608285428013,0,0,10.879757308328736,43.68009429377434,PRKN;MOB1B
95,GO_Biological_Process_2018,membrane assembly (GO:0071709),1/23,0.0182487894189074,0.0536608285428013,0,0,60.49090909090909,242.18482345145705,PTPRD
96,GO_Biological_Process_2018,cellular response to catecholamine stimulus (GO:0071870),1/23,0.0182487894189074,0.0536608285428013,0,0,60.49090909090909,242.18482345145705,PRKN
97,GO_Biological_Process_2018,divalent inorganic cation homeostasis (GO:0072507),1/23,0.0182487894189074,0.0536608285428013,0,0,60.49090909090909,242.18482345145705,PRKN
101,GO_Biological_Process_2018,negative regulation of cytoskeleton organization (GO:0051494),1/24,0.0190350912060612,0.0536608285428013,0,0,57.85797101449276,229.20267994354347,PRKN
99,GO_Biological_Process_2018,transition metal ion homeostasis (GO:0055076),1/24,0.0190350912060612,0.0536608285428013,0,0,57.85797101449276,229.20267994354347,PRKN
100,GO_Biological_Process_2018,proteoglycan biosynthetic process (GO:0030166),1/24,0.0190350912060612,0.0536608285428013,0,0,57.85797101449276,229.20267994354347,EXT1
90,GO_Biological_Process_2018,regulation of ERBB signaling pathway (GO:1901184),1/22,0.0174618968734111,0.0536608285428013,0,0,63.37460317460317,256.52354192445085,NRG1
102,GO_Biological_Process_2018,negative regulation of oxidative stress-induced cell death (GO:1903202),1/24,0.0190350912060612,0.0536608285428013,0,0,57.85797101449276,229.20267994354347,PRKN
103,GO_Biological_Process_2018,regulation of actin filament bundle assembly (GO:0032231),1/24,0.0190350912060612,0.0536608285428013,0,0,57.85797101449276,229.20267994354347,PRKN
104,GO_Biological_Process_2018,mammary gland development (GO:0030879),1/24,0.0190350912060612,0.0536608285428013,0,0,57.85797101449276,229.20267994354347,NRG1
98,GO_Biological_Process_2018,cellular response to ammonium ion (GO:0071242),1/23,0.0182487894189074,0.0536608285428013,0,0,60.49090909090909,242.18482345145705,PRKN
89,GO_Biological_Process_2018,regulation of catecholamine secretion (GO:0050433),1/22,0.0174618968734111,0.0536608285428013,0,0,63.37460317460317,256.52354192445085,PRKN
93,GO_Biological_Process_2018,cellular response to unfolded protein (GO:0034620),1/22,0.0174618968734111,0.0536608285428013,0,0,63.37460317460317,256.52354192445085,PRKN
87,GO_Biological_Process_2018,mitochondrial fission (GO:0000266),1/21,0.0166744131586755,0.0536608285428013,0,0,66.54666666666667,272.4340597931688,PRKN
88,GO_Biological_Process_2018,negative regulation of response to endoplasmic reticulum stress (GO:1903573),1/22,0.0174618968734111,0.0536608285428013,0,0,63.37460317460317,256.52354192445085,PRKN
71,GO_Biological_Process_2018,negative regulation of reactive oxygen species metabolic process (GO:2000378),1/17,0.0135185584535393,0.0536608285428013,0,0,83.2,358.0671608642671,PRKN
72,GO_Biological_Process_2018,regulation of protein localization to membrane (GO:1905475),1/17,0.0135185584535393,0.0536608285428013,0,0,83.2,358.0671608642671,PRKN
73,GO_Biological_Process_2018,positive regulation of striated muscle cell differentiation (GO:0051155),1/17,0.0135185584535393,0.0536608285428013,0,0,83.2,358.0671608642671,NRG1
74,GO_Biological_Process_2018,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),1/18,0.0143084109196949,0.0536608285428013,0,0,78.30196078431372,332.5412031884909,PRKN
75,GO_Biological_Process_2018,heart trabecula morphogenesis (GO:0061384),1/18,0.0143084109196949,0.0536608285428013,0,0,78.30196078431372,332.5412031884909,NRG1
76,GO_Biological_Process_2018,proteasomal protein catabolic process (GO:0010498),2/237,0.0150410336841925,0.0536608285428013,0,0,12.00547112462006,50.38664096942941,PRKN;BTBD9
77,GO_Biological_Process_2018,striated muscle cell differentiation (GO:0051146),1/19,0.0150976705893844,0.0536608285428013,0,0,73.94814814814815,310.08047018396815,NRG1
81,GO_Biological_Process_2018,negative regulation of actin filament bundle assembly (GO:0032232),1/20,0.0158863378646896,0.0536608285428013,0,0,70.05263157894737,290.1787210723924,PRKN
79,GO_Biological_Process_2018,regulation of mitochondrial fission (GO:0090140),1/19,0.0150976705893844,0.0536608285428013,0,0,73.94814814814815,310.08047018396815,PRKN
80,GO_Biological_Process_2018,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),1/20,0.0158863378646896,0.0536608285428013,0,0,70.05263157894737,290.1787210723924,PRKN
82,GO_Biological_Process_2018,heparan sulfate proteoglycan metabolic process (GO:0030201),1/20,0.0158863378646896,0.0536608285428013,0,0,70.05263157894737,290.1787210723924,EXT1
83,GO_Biological_Process_2018,regulation of transport (GO:0051049),1/20,0.0158863378646896,0.0536608285428013,0,0,70.05263157894737,290.1787210723924,PRKN
84,GO_Biological_Process_2018,dopamine metabolic process (GO:0042417),1/20,0.0158863378646896,0.0536608285428013,0,0,70.05263157894737,290.1787210723924,PRKN
85,GO_Biological_Process_2018,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/21,0.0166744131586755,0.0536608285428013,0,0,66.54666666666667,272.4340597931688,SMAD9
86,GO_Biological_Process_2018,protein O-linked glycosylation via threonine (GO:0018243),1/21,0.0166744131586755,0.0536608285428013,0,0,66.54666666666667,272.4340597931688,GALNTL6
78,GO_Biological_Process_2018,cellular polysaccharide biosynthetic process (GO:0033692),1/19,0.0150976705893844,0.0536608285428013,0,0,73.94814814814815,310.08047018396815,EXT1
536,GO_Biological_Process_2017b,"regulation of protein catabolic process at synapse, modulating synaptic transmission (GO:0099574)",1/19,0.0150976705893844,0.0538902964093305,0,0,73.94814814814815,310.08047018396815,BTBD9
537,GO_Biological_Process_2017b,regulation of neurotransmitter secretion (GO:0046928),1/19,0.0150976705893844,0.0538902964093305,0,0,73.94814814814815,310.08047018396815,BTBD9
538,GO_Biological_Process_2017b,positive regulation of dopamine secretion (GO:0033603),1/19,0.0150976705893844,0.0538902964093305,0,0,73.94814814814815,310.08047018396815,PRKN
539,GO_Biological_Process_2017b,pyridoxal phosphate metabolic process (GO:0042822),1/19,0.0150976705893844,0.0538902964093305,0,0,73.94814814814815,310.08047018396815,PTPRD
540,GO_Biological_Process_2017b,positive regulation of mitochondrion organization (GO:0010822),1/19,0.0150976705893844,0.0538902964093305,0,0,73.94814814814815,310.08047018396815,PRKN
541,GO_Biological_Process_2017b,negative regulation of cohesin unloading (GO:1905338),1/19,0.0150976705893844,0.0538902964093305,0,0,73.94814814814815,310.08047018396815,PRKN
542,GO_Biological_Process_2017b,membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),1/19,0.0150976705893844,0.0538902964093305,0,0,73.94814814814815,310.08047018396815,KCND3
543,GO_Biological_Process_2017b,GDP-mannose biosynthetic process from fructose-6-phosphate (GO:0061729),1/19,0.0150976705893844,0.0538902964093305,0,0,73.94814814814815,310.08047018396815,PTPRD
546,GO_Biological_Process_2017b,establishment of protein localization to mitochondrial membrane involved in mitochondrial fission (GO:0090152),1/20,0.0158863378646896,0.054196311918919,0,0,70.05263157894737,290.1787210723924,PRKN
545,GO_Biological_Process_2017b,regulation of protein desumoylation (GO:0060188),1/20,0.0158863378646896,0.054196311918919,0,0,70.05263157894737,290.1787210723924,BTBD9
547,GO_Biological_Process_2017b,negative regulation of release of cytochrome c from mitochondria (GO:0090201),1/20,0.0158863378646896,0.054196311918919,0,0,70.05263157894737,290.1787210723924,PRKN
548,GO_Biological_Process_2017b,regulation of protein deneddylation (GO:0060625),1/20,0.0158863378646896,0.054196311918919,0,0,70.05263157894737,290.1787210723924,BTBD9
550,GO_Biological_Process_2017b,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),1/20,0.0158863378646896,0.054196311918919,0,0,70.05263157894737,290.1787210723924,BTBD9
551,GO_Biological_Process_2017b,heparan sulfate proteoglycan biosynthetic process (GO:0015012),1/20,0.0158863378646896,0.054196311918919,0,0,70.05263157894737,290.1787210723924,EXT1
553,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0036091),1/20,0.0158863378646896,0.054196311918919,0,0,70.05263157894737,290.1787210723924,SMAD9
544,GO_Biological_Process_2017b,establishment of mitochondrion localization involved in mitochondrial fission (GO:0090146),1/20,0.0158863378646896,0.054196311918919,0,0,70.05263157894737,290.1787210723924,PRKN
552,GO_Biological_Process_2017b,glucose 6-phosphate metabolic process (GO:0051156),1/20,0.0158863378646896,0.054196311918919,0,0,70.05263157894737,290.1787210723924,PTPRD
549,GO_Biological_Process_2017b,mitochondrial nucleoid organization involved in mitochondrial fission (GO:0090145),1/20,0.0158863378646896,0.054196311918919,0,0,70.05263157894737,290.1787210723924,PRKN
561,GO_Biological_Process_2017b,neural crest cell development (GO:0014032),1/21,0.0166744131586755,0.0544744599378764,0,0,66.54666666666667,272.4340597931688,NRG1
554,GO_Biological_Process_2017b,ubiquitin-dependent ERAD pathway (GO:0030433),2/247,0.0162642122771522,0.0544744599378764,0,0,11.509620991253644,47.40569055870592,PRKN;BTBD9
555,GO_Biological_Process_2017b,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),2/249,0.0165138671657027,0.0544744599378764,0,0,11.415268941584731,46.84318184982494,PRKN;BTBD9
556,GO_Biological_Process_2017b,regulation of peptidase activity (GO:0052547),1/21,0.0166744131586755,0.0544744599378764,0,0,66.54666666666667,272.4340597931688,BTBD9
557,GO_Biological_Process_2017b,regulation of proteolysis (GO:0030162),1/21,0.0166744131586755,0.0544744599378764,0,0,66.54666666666667,272.4340597931688,BTBD9
558,GO_Biological_Process_2017b,regulation of protein processing (GO:0070613),1/21,0.0166744131586755,0.0544744599378764,0,0,66.54666666666667,272.4340597931688,BTBD9
559,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000079),1/21,0.0166744131586755,0.0544744599378764,0,0,66.54666666666667,272.4340597931688,PRKN
560,GO_Biological_Process_2017b,regulation of protein deubiquitination (GO:0090085),1/21,0.0166744131586755,0.0544744599378764,0,0,66.54666666666667,272.4340597931688,BTBD9
562,GO_Biological_Process_2017b,cardiac muscle cell differentiation (GO:0055007),1/21,0.0166744131586755,0.0544744599378764,0,0,66.54666666666667,272.4340597931688,NRG1
563,GO_Biological_Process_2017b,tyrosine catabolic process to phosphoenolpyruvate (GO:0019446),1/21,0.0166744131586755,0.0544744599378764,0,0,66.54666666666667,272.4340597931688,PTPRD
105,GO_Biological_Process_2018,regulation of glucose metabolic process (GO:0010906),1/25,0.0198208026407264,0.0553486564307078,0,0,55.44444444444444,217.3989559937,PRKN
567,GO_Biological_Process_2017b,fructose 6-phosphate metabolic process (GO:0006002),1/22,0.0174618968734111,0.0560963437058331,0,0,63.37460317460317,256.52354192445085,PTPRD
566,GO_Biological_Process_2017b,negative regulation of reactive oxygen species metabolic process (GO:2000378),1/22,0.0174618968734111,0.0560963437058331,0,0,63.37460317460317,256.52354192445085,PRKN
565,GO_Biological_Process_2017b,neural crest cell migration (GO:0001755),1/22,0.0174618968734111,0.0560963437058331,0,0,63.37460317460317,256.52354192445085,NRG1
564,GO_Biological_Process_2017b,positive regulation of mitochondrial fission (GO:0090141),1/22,0.0174618968734111,0.0560963437058331,0,0,63.37460317460317,256.52354192445085,PRKN
106,GO_Biological_Process_2018,positive regulation of synapse assembly (GO:0051965),1/26,0.0206059241328129,0.0570033041431087,0,0,53.224,206.6249708321616,PTPRD
571,GO_Biological_Process_2017b,glycerol to glycerone phosphate metabolic process (GO:0061610),1/23,0.0182487894189074,0.0571943765934049,0,0,60.49090909090909,242.18482345145705,PTPRD
568,GO_Biological_Process_2017b,membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),1/23,0.0182487894189074,0.0571943765934049,0,0,60.49090909090909,242.18482345145705,KCND3
569,GO_Biological_Process_2017b,cohesin loading (GO:0071921),1/23,0.0182487894189074,0.0571943765934049,0,0,60.49090909090909,242.18482345145705,PRKN
570,GO_Biological_Process_2017b,membrane repolarization during action potential (GO:0086011),1/23,0.0182487894189074,0.0571943765934049,0,0,60.49090909090909,242.18482345145705,KCND3
573,GO_Biological_Process_2017b,regulation of protein autophosphorylation (GO:0031952),1/23,0.0182487894189074,0.0571943765934049,0,0,60.49090909090909,242.18482345145705,MOB1B
572,GO_Biological_Process_2017b,"fructose 1,6-bisphosphate metabolic process (GO:0030388)",1/23,0.0182487894189074,0.0571943765934049,0,0,60.49090909090909,242.18482345145705,PTPRD
107,GO_Biological_Process_2018,regulation of autophagy of mitochondrion (GO:1903146),1/27,0.0213904560937906,0.058085151176225,0,0,51.174358974358974,196.7557093049865,PRKN
109,GO_Biological_Process_2018,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),2/291,0.0221322581775144,0.058085151176225,0,0,9.735541275333665,37.09941297639848,PRKN;BTBD9
110,GO_Biological_Process_2018,organelle fission (GO:0048285),1/28,0.0221743989287616,0.058085151176225,0,0,49.27654320987654,187.6853284304674,PRKN
112,GO_Biological_Process_2018,negative regulation of JNK cascade (GO:0046329),1/28,0.0221743989287616,0.058085151176225,0,0,49.27654320987654,187.6853284304674,PRKN
111,GO_Biological_Process_2018,protein K11-linked ubiquitination (GO:0070979),1/28,0.0221743989287616,0.058085151176225,0,0,49.27654320987654,187.6853284304674,PRKN
108,GO_Biological_Process_2018,cellular response to topologically incorrect protein (GO:0035967),1/27,0.0213904560937906,0.058085151176225,0,0,51.174358974358974,196.7557093049865,PRKN
575,GO_Biological_Process_2017b,positive regulation of DNA binding (GO:0043388),1/24,0.0190350912060612,0.0582383147614017,0,0,57.85797101449276,229.20267994354347,PRKN
574,GO_Biological_Process_2017b,positive regulation of cohesin loading (GO:1905309),1/24,0.0190350912060612,0.0582383147614017,0,0,57.85797101449276,229.20267994354347,PRKN
577,GO_Biological_Process_2017b,lactation (GO:0007595),1/24,0.0190350912060612,0.0582383147614017,0,0,57.85797101449276,229.20267994354347,NRG1
578,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060827),1/24,0.0190350912060612,0.0582383147614017,0,0,57.85797101449276,229.20267994354347,PRKN
579,GO_Biological_Process_2017b,mitochondrial membrane fission (GO:0090149),1/24,0.0190350912060612,0.0582383147614017,0,0,57.85797101449276,229.20267994354347,PRKN
576,GO_Biological_Process_2017b,negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179),1/24,0.0190350912060612,0.0582383147614017,0,0,57.85797101449276,229.20267994354347,PRKN
583,GO_Biological_Process_2017b,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),1/25,0.0198208026407264,0.0595025000239654,0,0,55.44444444444444,217.3989559937,PRKN
594,GO_Biological_Process_2017b,positive regulation of striated muscle cell differentiation (GO:0051155),1/26,0.0206059241328129,0.0595025000239654,0,0,53.224,206.6249708321616,NRG1
593,GO_Biological_Process_2017b,regulation of cilium-dependent cell motility (GO:1902019),1/26,0.0206059241328129,0.0595025000239654,0,0,53.224,206.6249708321616,NRG1
592,GO_Biological_Process_2017b,hippo signaling (GO:0035329),1/26,0.0206059241328129,0.0595025000239654,0,0,53.224,206.6249708321616,MOB1B
591,GO_Biological_Process_2017b,regulation of flagellated sperm motility (GO:1901317),1/26,0.0206059241328129,0.0595025000239654,0,0,53.224,206.6249708321616,NRG1
582,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905239),1/25,0.0198208026407264,0.0595025000239654,0,0,55.44444444444444,217.3989559937,PRKN
588,GO_Biological_Process_2017b,modulation by symbiont of host cell motility (GO:1903653),1/26,0.0206059241328129,0.0595025000239654,0,0,53.224,206.6249708321616,NRG1
587,GO_Biological_Process_2017b,regulation of bacterial-type flagellum-dependent cell motility (GO:1902021),1/26,0.0206059241328129,0.0595025000239654,0,0,53.224,206.6249708321616,NRG1
586,GO_Biological_Process_2017b,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/26,0.0206059241328129,0.0595025000239654,0,0,53.224,206.6249708321616,PRKN
585,GO_Biological_Process_2017b,negative regulation of oxidative stress-induced neuron death (GO:1903204),1/26,0.0206059241328129,0.0595025000239654,0,0,53.224,206.6249708321616,PRKN
584,GO_Biological_Process_2017b,regulation of amoeboid sperm motility (GO:1905416),1/26,0.0206059241328129,0.0595025000239654,0,0,53.224,206.6249708321616,NRG1
580,GO_Biological_Process_2017b,"regulation of synaptic transmission, glutamatergic (GO:0051966)",1/25,0.0198208026407264,0.0595025000239654,0,0,55.44444444444444,217.3989559937,BTBD9
581,GO_Biological_Process_2017b,neurexin clustering involved in presynaptic membrane assembly (GO:0097115),1/25,0.0198208026407264,0.0595025000239654,0,0,55.44444444444444,217.3989559937,PTPRD
590,GO_Biological_Process_2017b,modulation of inhibitory postsynaptic potential (GO:0098828),1/26,0.0206059241328129,0.0595025000239654,0,0,53.224,206.6249708321616,BTBD9
589,GO_Biological_Process_2017b,positive regulation of mitophagy (GO:1901526),1/26,0.0206059241328129,0.0595025000239654,0,0,53.224,206.6249708321616,PRKN
113,GO_Biological_Process_2018,cardiac muscle cell action potential (GO:0086001),1/29,0.0229577530466617,0.0596096044018585,0,0,47.51428571428571,179.32364557493287,KCND3
115,GO_Biological_Process_2018,activation of protein kinase B activity (GO:0032148),1/30,0.0237405188646141,0.0600614836232974,0,0,45.87356321839081,171.5933676703201,NRG1
114,GO_Biological_Process_2018,hippo signaling (GO:0035329),1/30,0.0237405188646141,0.0600614836232974,0,0,45.87356321839081,171.5933676703201,MOB1B
116,GO_Biological_Process_2018,negative regulation of stress-activated MAPK cascade (GO:0032873),1/30,0.0237405188646141,0.0600614836232974,0,0,45.87356321839081,171.5933676703201,PRKN
595,GO_Biological_Process_2017b,micromitophagy (GO:0000424),1/27,0.0213904560937906,0.0601899330230387,0,0,51.174358974358974,196.7557093049865,PRKN
601,GO_Biological_Process_2017b,negative regulation of ERBB signaling pathway (GO:1901185),1/27,0.0213904560937906,0.0601899330230387,0,0,51.174358974358974,196.7557093049865,NRG1
600,GO_Biological_Process_2017b,regulation of cell motility (GO:2000145),1/27,0.0213904560937906,0.0601899330230387,0,0,51.174358974358974,196.7557093049865,NRG1
599,GO_Biological_Process_2017b,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),1/27,0.0213904560937906,0.0601899330230387,0,0,51.174358974358974,196.7557093049865,PRKN
598,GO_Biological_Process_2017b,autophagy of mitochondrion (GO:0000422),1/27,0.0213904560937906,0.0601899330230387,0,0,51.174358974358974,196.7557093049865,PRKN
597,GO_Biological_Process_2017b,positive regulation of proteasomal protein catabolic process (GO:1901800),1/27,0.0213904560937906,0.0601899330230387,0,0,51.174358974358974,196.7557093049865,PRKN
596,GO_Biological_Process_2017b,protein destabilization (GO:0031648),1/27,0.0213904560937906,0.0601899330230387,0,0,51.174358974358974,196.7557093049865,PRKN
119,GO_Biological_Process_2018,zinc ion homeostasis (GO:0055069),1/31,0.0245226967845343,0.0604893187351846,0,0,44.34222222222222,164.42788585185278,PRKN
117,GO_Biological_Process_2018,protein destabilization (GO:0031648),1/31,0.0245226967845343,0.0604893187351846,0,0,44.34222222222222,164.42788585185278,PRKN
118,GO_Biological_Process_2018,regulation of protein autophosphorylation (GO:0031952),1/31,0.0245226967845343,0.0604893187351846,0,0,44.34222222222222,164.42788585185278,MOB1B
602,GO_Biological_Process_2017b,mitophagy (GO:0000423),1/28,0.0221743989287616,0.0617200778847479,0,0,49.27654320987654,187.6853284304674,PRKN
603,GO_Biological_Process_2017b,mitophagy by induced vacuole formation (GO:0035695),1/28,0.0221743989287616,0.0617200778847479,0,0,49.27654320987654,187.6853284304674,PRKN
604,GO_Biological_Process_2017b,"retrograde protein transport, ER to cytosol (GO:0030970)",1/28,0.0221743989287616,0.0617200778847479,0,0,49.27654320987654,187.6853284304674,PRKN
605,GO_Biological_Process_2017b,protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process (GO:1901044),2/292,0.0222745626866601,0.0617758555086869,0,0,9.701477832512316,36.90742853433792,PRKN;BTBD9
120,GO_Biological_Process_2018,positive regulation of dendrite development (GO:1900006),1/32,0.0253042872146084,0.0619013968225131,0,0,42.90967741935484,157.76950563835985,PTPRD
125,GO_Biological_Process_2018,positive regulation of DNA binding (GO:0043388),1/34,0.0268657072594049,0.0621269480373739,0,0,40.3050505050505,145.77952373263088,PRKN
123,GO_Biological_Process_2018,positive regulation of cytokine-mediated signaling pathway (GO:0001961),1/33,0.0260852905726611,0.0621269480373739,0,0,41.56666666666667,151.56801592617538,PRKN
122,GO_Biological_Process_2018,negative regulation of mitochondrion organization (GO:0010823),1/33,0.0260852905726611,0.0621269480373739,0,0,41.56666666666667,151.56801592617538,PRKN
121,GO_Biological_Process_2018,oligosaccharide biosynthetic process (GO:0009312),1/33,0.0260852905726611,0.0621269480373739,0,0,41.56666666666667,151.56801592617538,GALNTL6
126,GO_Biological_Process_2018,positive regulation of muscle cell differentiation (GO:0051149),1/34,0.0268657072594049,0.0621269480373739,0,0,40.3050505050505,145.77952373263088,NRG1
127,GO_Biological_Process_2018,ventricular cardiac muscle tissue morphogenesis (GO:0055010),1/34,0.0268657072594049,0.0621269480373739,0,0,40.3050505050505,145.77952373263088,NRG1
124,GO_Biological_Process_2018,negative regulation of cellular metabolic process (GO:0031324),1/34,0.0268657072594049,0.0621269480373739,0,0,40.3050505050505,145.77952373263088,PRKN
128,GO_Biological_Process_2018,regulation of heart rate by cardiac conduction (GO:0086091),1/35,0.0276455376880297,0.0624662530966168,0,0,39.11764705882353,140.36549891248842,KCND3
130,GO_Biological_Process_2018,regulation of synapse assembly (GO:0051963),1/35,0.0276455376880297,0.0624662530966168,0,0,39.11764705882353,140.36549891248842,PTPRD
129,GO_Biological_Process_2018,neural crest cell development (GO:0014032),1/35,0.0276455376880297,0.0624662530966168,0,0,39.11764705882353,140.36549891248842,NRG1
608,GO_Biological_Process_2017b,positive regulation of dendrite morphogenesis (GO:0050775),1/29,0.0229577530466617,0.0627674737552347,0,0,47.51428571428571,179.32364557493287,PTPRD
606,GO_Biological_Process_2017b,negative regulation of stress fiber assembly (GO:0051497),1/29,0.0229577530466617,0.0627674737552347,0,0,47.51428571428571,179.32364557493287,PRKN
607,GO_Biological_Process_2017b,modulation of excitatory postsynaptic potential (GO:0098815),1/29,0.0229577530466617,0.0627674737552347,0,0,47.51428571428571,179.32364557493287,BTBD9
609,GO_Biological_Process_2017b,positive regulation of transcription regulatory region DNA binding (GO:2000679),1/29,0.0229577530466617,0.0627674737552347,0,0,47.51428571428571,179.32364557493287,PRKN
131,GO_Biological_Process_2018,cardiac muscle tissue development (GO:0048738),1/36,0.0284247822669753,0.0632611695565767,0,0,37.99809523809524,135.29198627979454,NRG1
132,GO_Biological_Process_2018,carbohydrate biosynthetic process (GO:0016051),1/36,0.0284247822669753,0.0632611695565767,0,0,37.99809523809524,135.29198627979454,GALNTL6
610,GO_Biological_Process_2017b,"regulation of translation at synapse, modulating synaptic transmission (GO:0099547)",1/30,0.0237405188646141,0.0637767945805489,0,0,45.87356321839081,171.5933676703201,BTBD9
611,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway (GO:0060828),1/30,0.0237405188646141,0.0637767945805489,0,0,45.87356321839081,171.5933676703201,PRKN
613,GO_Biological_Process_2017b,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),1/30,0.0237405188646141,0.0637767945805489,0,0,45.87356321839081,171.5933676703201,PRKN
614,GO_Biological_Process_2017b,ER-associated misfolded protein catabolic process (GO:0071712),1/30,0.0237405188646141,0.0637767945805489,0,0,45.87356321839081,171.5933676703201,PRKN
612,GO_Biological_Process_2017b,phenylalanine catabolic process to phosphoenolpyruvate (GO:0019562),1/30,0.0237405188646141,0.0637767945805489,0,0,45.87356321839081,171.5933676703201,PTPRD
134,GO_Biological_Process_2018,protein monoubiquitination (GO:0006513),1/37,0.0292034414014455,0.0640312492950213,0,0,36.94074074074074,130.52895191723596,PRKN
133,GO_Biological_Process_2018,protein K63-linked ubiquitination (GO:0070534),1/37,0.0292034414014455,0.0640312492950213,0,0,36.94074074074074,130.52895191723596,PRKN
135,GO_Biological_Process_2018,ubiquitin-dependent protein catabolic process (GO:0006511),2/341,0.0297101212091243,0.0646632049845646,0,0,8.278550358196377,29.109597652556285,PRKN;BTBD9
136,GO_Biological_Process_2018,mitochondrion disassembly (GO:0061726),1/38,0.0299815155053699,0.0647775809459088,0,0,35.94054054054054,126.04973784905,PRKN
615,GO_Biological_Process_2017b,mitochondrial DNA inheritance (GO:0033955),1/31,0.0245226967845343,0.0654221426327887,0,0,44.34222222222222,164.42788585185278,PRKN
616,GO_Biological_Process_2017b,ventricular trabecula myocardium morphogenesis (GO:0003222),1/31,0.0245226967845343,0.0654221426327887,0,0,44.34222222222222,164.42788585185278,NRG1
137,GO_Biological_Process_2018,regulation of proteasomal protein catabolic process (GO:0061136),1/39,0.0307590049844483,0.0655011904704798,0,0,34.99298245614035,121.8306048026202,PRKN
138,GO_Biological_Process_2018,ERBB2 signaling pathway (GO:0038128),1/39,0.0307590049844483,0.0655011904704798,0,0,34.99298245614035,121.8306048026202,NRG1
141,GO_Biological_Process_2018,regulation of intracellular transport (GO:0032386),1/40,0.0315359102498904,0.0657368269997717,0,0,34.0940170940171,117.85034688899692,PRKN
140,GO_Biological_Process_2018,autophagy of mitochondrion (GO:0000422),1/40,0.0315359102498904,0.0657368269997717,0,0,34.0940170940171,117.85034688899692,PRKN
139,GO_Biological_Process_2018,regulation of release of cytochrome c from mitochondria (GO:0090199),1/40,0.0315359102498904,0.0657368269997717,0,0,34.0940170940171,117.85034688899692,PRKN
142,GO_Biological_Process_2018,regulation of cellular metabolic process (GO:0031323),1/41,0.0323122317033933,0.0668840600294017,0,0,33.24,114.08996545091124,PRKN
617,GO_Biological_Process_2017b,positive regulation of proteasome-activating ATPase activity (GO:1902887),1/32,0.0253042872146084,0.0670433176716944,0,0,42.90967741935484,157.76950563835985,PRKN
618,GO_Biological_Process_2017b,regulation of cell motility involved in somitogenic axis elongation (GO:0090249),1/32,0.0253042872146084,0.0670433176716944,0,0,42.90967741935484,157.76950563835985,NRG1
143,GO_Biological_Process_2018,negative regulation of protein secretion (GO:0050709),1/42,0.033087969760152,0.0680141600625348,0,0,32.427642276422766,110.53239171718836,PRKN
620,GO_Biological_Process_2017b,low-density lipoprotein particle receptor catabolic process (GO:0032802),1/33,0.0260852905726611,0.0686408158072415,0,0,41.56666666666667,151.56801592617538,PRKN
619,GO_Biological_Process_2017b,"protein catabolic process, modulating synaptic transmission (GO:0099546)",1/33,0.0260852905726611,0.0686408158072415,0,0,41.56666666666667,151.56801592617538,BTBD9
145,GO_Biological_Process_2018,response to unfolded protein (GO:0006986),1/43,0.0338631248228564,0.0686540064901748,0,0,31.65396825396825,107.16225006283427,PRKN
144,GO_Biological_Process_2018,negative regulation of ERBB signaling pathway (GO:1901185),1/43,0.0338631248228564,0.0686540064901748,0,0,31.65396825396825,107.16225006283427,NRG1
146,GO_Biological_Process_2018,regulation of dendrite morphogenesis (GO:0048814),1/44,0.0346376973079083,0.0697466558036794,0,0,30.91627906976744,103.96565504057872,PTPRD
623,GO_Biological_Process_2017b,regulation of membrane protein ectodomain proteolysis (GO:0051043),1/34,0.0268657072594049,0.0699779064087879,0,0,40.3050505050505,145.77952373263088,BTBD9
622,GO_Biological_Process_2017b,substrate localization to autophagosome (GO:0061753),1/34,0.0268657072594049,0.0699779064087879,0,0,40.3050505050505,145.77952373263088,ATG16L1
621,GO_Biological_Process_2017b,regulation of heart rate by cardiac conduction (GO:0086091),1/34,0.0268657072594049,0.0699779064087879,0,0,40.3050505050505,145.77952373263088,KCND3
147,GO_Biological_Process_2018,protein polymerization (GO:0051258),1/45,0.0354116876094494,0.0708233752188989,0,0,30.21212121212121,100.93003681239615,PRKN
148,GO_Biological_Process_2018,aminoglycan biosynthetic process (GO:0006023),1/46,0.0361850961442075,0.0714052563912361,0,0,29.53925925925926,98.04399035231516,EXT1
149,GO_Biological_Process_2018,regulation of cellular component movement (GO:0051270),1/46,0.0361850961442075,0.0714052563912361,0,0,29.53925925925926,98.04399035231516,NRG1
625,GO_Biological_Process_2017b,positive regulation of dendritic spine morphogenesis (GO:0061003),1/35,0.0276455376880297,0.0715258709982246,0,0,39.11764705882353,140.36549891248842,PTPRD
624,GO_Biological_Process_2017b,autophagosome assembly (GO:0000045),1/35,0.0276455376880297,0.0715258709982246,0,0,39.11764705882353,140.36549891248842,ATG16L1
150,GO_Biological_Process_2018,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/47,0.0369579233170905,0.0724473198798596,0,0,28.89565217391304,95.29714486695592,PTPRD
153,GO_Biological_Process_2018,cellular macromolecule catabolic process (GO:0044265),1/48,0.0377301695361429,0.0725203258616773,0,0,28.279432624113475,92.68005025728142,PRKN
151,GO_Biological_Process_2018,protein K48-linked ubiquitination (GO:0070936),1/48,0.0377301695361429,0.0725203258616773,0,0,28.279432624113475,92.68005025728142,PRKN
152,GO_Biological_Process_2018,regulation of mitochondrion organization (GO:0010821),1/48,0.0377301695361429,0.0725203258616773,0,0,28.279432624113475,92.68005025728142,PRKN
629,GO_Biological_Process_2017b,central nervous system development (GO:0007417),2/333,0.0284356247826099,0.0725955851238154,0,0,8.48208890807078,30.19719096958858,PRKN;NRG1
628,GO_Biological_Process_2017b,cellular response to unfolded protein (GO:0034620),1/36,0.0284247822669753,0.0725955851238154,0,0,37.99809523809524,135.29198627979454,PRKN
627,GO_Biological_Process_2017b,wound healing (GO:0042060),1/36,0.0284247822669753,0.0725955851238154,0,0,37.99809523809524,135.29198627979454,NRG1
626,GO_Biological_Process_2017b,epiboly involved in wound healing (GO:0090505),1/36,0.0284247822669753,0.0725955851238154,0,0,37.99809523809524,135.29198627979454,NRG1
636,GO_Biological_Process_2017b,wound healing involved in inflammatory response (GO:0002246),1/37,0.0292034414014455,0.072866839224966,0,0,36.94074074074074,130.52895191723596,NRG1
634,GO_Biological_Process_2017b,negative regulation of oxidative stress-induced cell death (GO:1903202),1/37,0.0292034414014455,0.072866839224966,0,0,36.94074074074074,130.52895191723596,PRKN
633,GO_Biological_Process_2017b,negative regulation of JNK cascade (GO:0046329),1/37,0.0292034414014455,0.072866839224966,0,0,36.94074074074074,130.52895191723596,PRKN
632,GO_Biological_Process_2017b,negative regulation of necrotic cell death (GO:0060547),1/37,0.0292034414014455,0.072866839224966,0,0,36.94074074074074,130.52895191723596,PRKN
631,GO_Biological_Process_2017b,peptidoglycan biosynthetic process (GO:0009252),1/37,0.0292034414014455,0.072866839224966,0,0,36.94074074074074,130.52895191723596,EXT1
635,GO_Biological_Process_2017b,positive regulation of reactive oxygen species metabolic process (GO:2000379),1/37,0.0292034414014455,0.072866839224966,0,0,36.94074074074074,130.52895191723596,PRKN
630,GO_Biological_Process_2017b,galactosaminoglycan biosynthetic process (GO:0006025),1/37,0.0292034414014455,0.072866839224966,0,0,36.94074074074074,130.52895191723596,EXT1
154,GO_Biological_Process_2018,regulation of reactive oxygen species metabolic process (GO:2000377),1/49,0.0385018352066202,0.0730547642382025,0,0,27.68888888888889,90.18407814256835,PRKN
155,GO_Biological_Process_2018,protein autoubiquitination (GO:0051865),1/49,0.0385018352066202,0.0730547642382025,0,0,27.68888888888889,90.18407814256835,PRKN
156,GO_Biological_Process_2018,regulation of ion transport (GO:0043269),1/50,0.0392729207344652,0.0731118524364887,0,0,27.12244897959184,87.80133530116419,PRKN
157,GO_Biological_Process_2018,negative regulation of viral genome replication (GO:0045071),1/50,0.0392729207344652,0.0731118524364887,0,0,27.12244897959184,87.80133530116419,PRKN
158,GO_Biological_Process_2018,wound healing (GO:0042060),1/50,0.0392729207344652,0.0731118524364887,0,0,27.12244897959184,87.80133530116419,NRG1
637,GO_Biological_Process_2017b,histone H2A K63-linked ubiquitination (GO:0070535),1/38,0.0299815155053699,0.0736170332950326,0,0,35.94054054054054,126.04973784905,PRKN
638,GO_Biological_Process_2017b,regulation of synaptic vesicle exocytosis (GO:2000300),1/38,0.0299815155053699,0.0736170332950326,0,0,35.94054054054054,126.04973784905,PRKN
639,GO_Biological_Process_2017b,angiogenesis involved in wound healing (GO:0060055),1/38,0.0299815155053699,0.0736170332950326,0,0,35.94054054054054,126.04973784905,NRG1
640,GO_Biological_Process_2017b,ERBB2-ERBB4 signaling pathway (GO:0038135),1/38,0.0299815155053699,0.0736170332950326,0,0,35.94054054054054,126.04973784905,NRG1
641,GO_Biological_Process_2017b,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),1/38,0.0299815155053699,0.0736170332950326,0,0,35.94054054054054,126.04973784905,PRKN
642,GO_Biological_Process_2017b,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),2/344,0.0301939739213582,0.0739033456932293,0,0,8.2046783625731,28.71730068828224,PRKN;BTBD9
159,GO_Biological_Process_2018,response to organonitrogen compound (GO:0010243),1/51,0.0400434265231351,0.0740803390678,0,0,26.578666666666667,85.52458776582635,PRKN
160,GO_Biological_Process_2018,regulation of DNA binding (GO:0051101),1/52,0.040813352985687,0.0745725461960702,0,0,26.0562091503268,83.34719406663498,PRKN
161,GO_Biological_Process_2018,positive regulation of nervous system development (GO:0051962),1/52,0.040813352985687,0.0745725461960702,0,0,26.0562091503268,83.34719406663498,PTPRD
643,GO_Biological_Process_2017b,negative regulation of cell motility (GO:2000146),1/39,0.0307590049844483,0.0745760781226718,0,0,34.99298245614035,121.8306048026202,NRG1
644,GO_Biological_Process_2017b,ERBB2-ERBB3 signaling pathway (GO:0038133),1/39,0.0307590049844483,0.0745760781226718,0,0,34.99298245614035,121.8306048026202,NRG1
645,GO_Biological_Process_2017b,histone monoubiquitination (GO:0010390),1/39,0.0307590049844483,0.0745760781226718,0,0,34.99298245614035,121.8306048026202,PRKN
652,GO_Biological_Process_2017b,heparin biosynthetic process (GO:0030210),1/40,0.0315359102498904,0.0748128824697401,0,0,34.0940170940171,117.85034688899692,EXT1
650,GO_Biological_Process_2017b,positive regulation of Ras GTPase binding (GO:1904477),1/40,0.0315359102498904,0.0748128824697401,0,0,34.0940170940171,117.85034688899692,PRKN
651,GO_Biological_Process_2017b,positive regulation of C-C chemokine binding (GO:2001265),1/40,0.0315359102498904,0.0748128824697401,0,0,34.0940170940171,117.85034688899692,PRKN
648,GO_Biological_Process_2017b,positive regulation of collagen binding (GO:0033343),1/40,0.0315359102498904,0.0748128824697401,0,0,34.0940170940171,117.85034688899692,PRKN
649,GO_Biological_Process_2017b,positive regulation of apolipoprotein binding (GO:2000658),1/40,0.0315359102498904,0.0748128824697401,0,0,34.0940170940171,117.85034688899692,PRKN
647,GO_Biological_Process_2017b,engulfment of target by autophagosome (GO:0061736),1/40,0.0315359102498904,0.0748128824697401,0,0,34.0940170940171,117.85034688899692,ATG16L1
646,GO_Biological_Process_2017b,positive regulation of actin binding (GO:1904618),1/40,0.0315359102498904,0.0748128824697401,0,0,34.0940170940171,117.85034688899692,PRKN
653,GO_Biological_Process_2017b,positive regulation of protein targeting to membrane (GO:0090314),1/41,0.0323122317033933,0.0757225855419948,0,0,33.24,114.08996545091124,PRKN
654,GO_Biological_Process_2017b,positive regulation of heparan sulfate proteoglycan binding (GO:1905860),1/41,0.0323122317033933,0.0757225855419948,0,0,33.24,114.08996545091124,PRKN
655,GO_Biological_Process_2017b,ERBB2 signaling pathway (GO:0038128),1/41,0.0323122317033933,0.0757225855419948,0,0,33.24,114.08996545091124,NRG1
656,GO_Biological_Process_2017b,positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),1/41,0.0323122317033933,0.0757225855419948,0,0,33.24,114.08996545091124,PRKN
659,GO_Biological_Process_2017b,suppression by virus of host protein phosphorylation (GO:0039613),1/42,0.033087969760152,0.0761517154778425,0,0,32.427642276422766,110.53239171718836,PRKN
657,GO_Biological_Process_2017b,negative regulation of proteolysis (GO:0045861),1/42,0.033087969760152,0.0761517154778425,0,0,32.427642276422766,110.53239171718836,BTBD9
658,GO_Biological_Process_2017b,positive regulation of microtubule binding (GO:1904528),1/42,0.033087969760152,0.0761517154778425,0,0,32.427642276422766,110.53239171718836,PRKN
660,GO_Biological_Process_2017b,regulation of autophagy (GO:0010506),1/42,0.033087969760152,0.0761517154778425,0,0,32.427642276422766,110.53239171718836,PRKN
661,GO_Biological_Process_2017b,positive regulation of receptor binding (GO:1900122),1/42,0.033087969760152,0.0761517154778425,0,0,32.427642276422766,110.53239171718836,PRKN
662,GO_Biological_Process_2017b,regulation of protein targeting to vacuole involved in autophagy (GO:1904051),1/42,0.033087969760152,0.0761517154778425,0,0,32.427642276422766,110.53239171718836,PRKN
668,GO_Biological_Process_2017b,cellular response to BMP stimulus (GO:0071773),1/43,0.0338631248228564,0.0765644259191271,0,0,31.65396825396825,107.16225006283427,SMAD9
666,GO_Biological_Process_2017b,negative regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901408),1/43,0.0338631248228564,0.0765644259191271,0,0,31.65396825396825,107.16225006283427,PRKN
664,GO_Biological_Process_2017b,epidermal growth factor catabolic process (GO:0007174),1/43,0.0338631248228564,0.0765644259191271,0,0,31.65396825396825,107.16225006283427,PRKN
667,GO_Biological_Process_2017b,negative regulation of cell death (GO:0060548),1/43,0.0338631248228564,0.0765644259191271,0,0,31.65396825396825,107.16225006283427,PRKN
663,GO_Biological_Process_2017b,hyaluronan biosynthetic process (GO:0030213),1/43,0.0338631248228564,0.0765644259191271,0,0,31.65396825396825,107.16225006283427,EXT1
665,GO_Biological_Process_2017b,sucrose catabolic process via 3'-ketosucrose (GO:0019574),1/43,0.0338631248228564,0.0765644259191271,0,0,31.65396825396825,107.16225006283427,PTPRD
162,GO_Biological_Process_2018,negative regulation of supramolecular fiber organization (GO:1902904),1/54,0.0423514695379364,0.0769081900811606,0,0,25.07044025157233,79.26651858378708,PRKN
669,GO_Biological_Process_2017b,positive regulation of elastin catabolic process (GO:0110015),1/44,0.0346376973079083,0.0774077235489777,0,0,30.91627906976744,103.96565504057872,PRKN
671,GO_Biological_Process_2017b,negative regulation of protein ubiquitination (GO:0031397),1/44,0.0346376973079083,0.0774077235489777,0,0,30.91627906976744,103.96565504057872,PRKN
672,GO_Biological_Process_2017b,activation of protein kinase B activity (GO:0032148),1/44,0.0346376973079083,0.0774077235489777,0,0,30.91627906976744,103.96565504057872,NRG1
670,GO_Biological_Process_2017b,dephosphorylation (GO:0016311),1/44,0.0346376973079083,0.0774077235489777,0,0,30.91627906976744,103.96565504057872,PTPRD
163,GO_Biological_Process_2018,regulation of cellular catabolic process (GO:0031329),1/55,0.0431196604465476,0.0778257286108421,0,0,24.604938271604937,77.3524200057788,PRKN
164,GO_Biological_Process_2018,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),1/56,0.0438872736413355,0.0782568252881646,0,0,24.15636363636364,75.5159546794018,PRKN
165,GO_Biological_Process_2018,autophagosome organization (GO:1905037),1/56,0.0438872736413355,0.0782568252881646,0,0,24.15636363636364,75.5159546794018,ATG16L1
673,GO_Biological_Process_2017b,plasma membrane repair (GO:0001778),1/45,0.0354116876094494,0.0789087027366633,0,0,30.21212121212121,100.93003681239615,NRG1
674,GO_Biological_Process_2017b,phosphorylation (GO:0016310),1/46,0.0361850961442075,0.079938994633765,0,0,29.53925925925926,98.04399035231516,PTPRD
675,GO_Biological_Process_2017b,negative regulation of histone phosphorylation (GO:0033128),1/46,0.0361850961442075,0.079938994633765,0,0,29.53925925925926,98.04399035231516,PRKN
676,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion (GO:0061400),1/46,0.0361850961442075,0.079938994633765,0,0,29.53925925925926,98.04399035231516,SMAD9
166,GO_Biological_Process_2018,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/58,0.0454207685297007,0.0800270683618536,0,0,23.30643274853801,72.05849833180837,PTPRD
167,GO_Biological_Process_2018,autophagosome assembly (GO:0000045),1/58,0.0454207685297007,0.0800270683618536,0,0,23.30643274853801,72.05849833180837,ATG16L1
168,GO_Biological_Process_2018,regulation of protein metabolic process (GO:0051246),1/59,0.0461866510315301,0.0808949627534492,0,0,22.90344827586207,70.42957983562586,BTBD9
679,GO_Biological_Process_2017b,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/47,0.0369579233170905,0.0809504513564682,0,0,28.89565217391304,95.29714486695592,PTPRD
677,GO_Biological_Process_2017b,negative regulation of programmed cell death (GO:0043069),1/47,0.0369579233170905,0.0809504513564682,0,0,28.89565217391304,95.29714486695592,PRKN
678,GO_Biological_Process_2017b,positive regulation of cell motility (GO:2000147),1/47,0.0369579233170905,0.0809504513564682,0,0,28.89565217391304,95.29714486695592,NRG1
170,GO_Biological_Process_2018,glycosaminoglycan metabolic process (GO:0030203),1/61,0.0477166881586132,0.0814321204040532,0,0,22.137777777777774,67.35361520384504,EXT1
178,GO_Biological_Process_2018,regulation of proteolysis (GO:0030162),1/63,0.0492444241632619,0.0814321204040532,0,0,21.421505376344086,64.49927724978124,BTBD9
176,GO_Biological_Process_2018,negative regulation of protein modification process (GO:0031400),1/63,0.0492444241632619,0.0814321204040532,0,0,21.421505376344086,64.49927724978124,PRKN
175,GO_Biological_Process_2018,negative regulation of neuron apoptotic process (GO:0043524),1/63,0.0492444241632619,0.0814321204040532,0,0,21.421505376344086,64.49927724978124,PRKN
174,GO_Biological_Process_2018,cellular protein catabolic process (GO:0044257),1/62,0.048480843602201,0.0814321204040532,0,0,21.77377049180328,65.90020061578312,PRKN
173,GO_Biological_Process_2018,positive regulation of catabolic process (GO:0009896),1/62,0.048480843602201,0.0814321204040532,0,0,21.77377049180328,65.90020061578312,PRKN
172,GO_Biological_Process_2018,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1/62,0.048480843602201,0.0814321204040532,0,0,21.77377049180328,65.90020061578312,PRKN
171,GO_Biological_Process_2018,potassium ion transport (GO:0006813),1/61,0.0477166881586132,0.0814321204040532,0,0,22.137777777777774,67.35361520384504,KCND3
169,GO_Biological_Process_2018,positive regulation of protein binding (GO:0032092),1/60,0.0469519574385199,0.0814321204040532,0,0,22.51412429378531,68.86238459395226,PRKN
177,GO_Biological_Process_2018,oligosaccharide metabolic process (GO:0009311),1/63,0.0492444241632619,0.0814321204040532,0,0,21.421505376344086,64.49927724978124,GALNTL6
681,GO_Biological_Process_2017b,negative regulation of inhibitory G-protein coupled receptor phosphorylation (GO:1904324),1/48,0.0377301695361429,0.0821750302609215,0,0,28.279432624113475,92.68005025728142,PRKN
680,GO_Biological_Process_2017b,glycosaminoglycan biosynthetic process (GO:0006024),1/48,0.0377301695361429,0.0821750302609215,0,0,28.279432624113475,92.68005025728142,EXT1
179,GO_Biological_Process_2018,nervous system development (GO:0007399),2/455,0.0502159471693465,0.0825707649892534,0,0,6.159255755282246,18.42493705052828,PRKN;NRG1
180,GO_Biological_Process_2018,O-glycan processing (GO:0016266),1/65,0.0507698622569058,0.0825707649892534,0,0,20.75,61.84438653446941,GALNTL6
181,GO_Biological_Process_2018,negative regulation of apoptotic signaling pathway (GO:2001234),1/65,0.0507698622569058,0.0825707649892534,0,0,20.75,61.84438653446941,PRKN
182,GO_Biological_Process_2018,positive regulation of cellular protein localization (GO:1903829),1/66,0.0515317205977756,0.083351854081648,0,0,20.42974358974359,60.58558396287635,PRKN
683,GO_Biological_Process_2017b,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),1/49,0.0385018352066202,0.0833845925401804,0,0,27.68888888888889,90.18407814256835,NRG1
682,GO_Biological_Process_2017b,modulation by virus of host autophagy (GO:0039519),1/49,0.0385018352066202,0.0833845925401804,0,0,27.68888888888889,90.18407814256835,PRKN
183,GO_Biological_Process_2018,positive regulation of autophagy (GO:0010508),1/67,0.0522930056729502,0.0841235308651807,0,0,20.11919191919192,59.3695755904207,PRKN
684,GO_Biological_Process_2017b,negative regulation of protein homodimerization activity (GO:0090074),1/50,0.0392729207344652,0.0845793907437784,0,0,27.12244897959184,87.80133530116419,NRG1
685,GO_Biological_Process_2017b,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),1/50,0.0392729207344652,0.0845793907437784,0,0,27.12244897959184,87.80133530116419,EXT1
687,GO_Biological_Process_2017b,negative regulation by host of viral genome replication (GO:0044828),1/51,0.0400434265231351,0.0857596718037144,0,0,26.578666666666667,85.52458776582635,PRKN
686,GO_Biological_Process_2017b,dermatan sulfate biosynthetic process (GO:0030208),1/51,0.0400434265231351,0.0857596718037144,0,0,26.578666666666667,85.52458776582635,EXT1
308,WikiPathways_2019_Human,BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation WP3876,1/13,0.0103532125188836,0.0862393208930953,0,0,110.95555555555556,507.11775303850175,SMAD9
311,WikiPathways_2019_Human,Differentiation of white and brown adipocyte    WP2895,1/25,0.0198208026407264,0.0862393208930953,0,0,55.44444444444444,217.3989559937,SMAD9
317,WikiPathways_2019_Human,Cardiac Hypertrophic Response WP2795,1/55,0.0431196604465476,0.0862393208930953,0,0,24.604938271604937,77.3524200057788,NRG1
310,WikiPathways_2019_Human,Nanoparticle triggered autophagic cell death WP2509,1/23,0.0182487894189074,0.0862393208930953,0,0,60.49090909090909,242.18482345145705,ATG16L1
309,WikiPathways_2019_Human,Neovascularisation processes WP4331,1/21,0.0166744131586755,0.0862393208930953,0,0,66.54666666666667,272.4340597931688,SMAD9
312,WikiPathways_2019_Human,Parkinsons Disease Pathway WP2371,1/38,0.0299815155053699,0.0862393208930953,0,0,35.94054054054054,126.04973784905,PRKN
313,WikiPathways_2019_Human,Sleep regulation WP3591,1/38,0.0299815155053699,0.0862393208930953,0,0,35.94054054054054,126.04973784905,BTBD9
314,WikiPathways_2019_Human,Cardiac Progenitor Differentiation WP2406,1/53,0.0415827005217073,0.0862393208930953,0,0,25.553846153846155,81.26304639681278,NRG1
315,WikiPathways_2019_Human,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,1/53,0.0415827005217073,0.0862393208930953,0,0,25.553846153846155,81.26304639681278,NRG1
316,WikiPathways_2019_Human,TGF-beta Receptor Signaling WP560,1/54,0.0423514695379364,0.0862393208930953,0,0,25.07044025157233,79.26651858378708,SMAD9
185,GO_Biological_Process_2018,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/70,0.0545734252963437,0.0868480316543964,0,0,19.24154589371981,55.958422143360416,PRKN
184,GO_Biological_Process_2018,negative regulation of developmental process (GO:0051093),1/70,0.0545734252963437,0.0868480316543964,0,0,19.24154589371981,55.958422143360416,PRKN
187,GO_Biological_Process_2018,regulation of cell communication (GO:0010646),1/71,0.0553324213162424,0.0871191314340838,0,0,18.965714285714284,54.89429252839914,BTBD9
186,GO_Biological_Process_2018,positive regulation of intracellular signal transduction (GO:1902533),2/479,0.0550460704893193,0.0871191314340838,0,0,5.842168313866427,16.939862436777783,PRKN;NRG1
688,GO_Biological_Process_2017b,mitochondrion to lysosome transport (GO:0099074),1/52,0.040813352985687,0.0871664685649992,0,0,26.0562091503268,83.34719406663498,PRKN
189,GO_Biological_Process_2018,lysosomal transport (GO:0007041),1/72,0.0560908460725308,0.0873836338814164,0,0,18.697652582159623,53.86387318021709,PRKN
188,GO_Biological_Process_2018,regulation of neuron death (GO:1901214),1/72,0.0560908460725308,0.0873836338814164,0,0,18.697652582159623,53.86387318021709,PRKN
190,GO_Biological_Process_2018,positive regulation of proteasomal protein catabolic process (GO:1901800),1/73,0.0568486999685374,0.0881006030926025,0,0,18.43703703703704,52.8656580429068,PRKN
689,GO_Biological_Process_2017b,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),1/53,0.0415827005217073,0.0885642599509291,0,0,25.553846153846155,81.26304639681278,PRKN
191,GO_Biological_Process_2018,negative regulation of phosphorylation (GO:0042326),1/75,0.0583626967999995,0.0895096282528491,0,0,17.936936936936938,50.96024313698236,PRKN
192,GO_Biological_Process_2018,gland development (GO:0048732),1/75,0.0583626967999995,0.0895096282528491,0,0,17.936936936936938,50.96024313698236,NRG1
690,GO_Biological_Process_2017b,positive regulation of proteolysis (GO:0045862),1/55,0.0431196604465476,0.0910828991898308,0,0,24.604938271604937,77.3524200057788,BTBD9
691,GO_Biological_Process_2017b,epidermal growth factor receptor signaling pathway (GO:0007173),1/55,0.0431196604465476,0.0910828991898308,0,0,24.604938271604937,77.3524200057788,NRG1
692,GO_Biological_Process_2017b,positive regulation of protein binding (GO:0032092),1/55,0.0431196604465476,0.0910828991898308,0,0,24.604938271604937,77.3524200057788,PRKN
193,GO_Biological_Process_2018,ERAD pathway (GO:0036503),1/77,0.0598744149956941,0.0913547775192033,0,0,17.46315789473684,49.16762572200828,PRKN
194,GO_Biological_Process_2018,protein ubiquitination (GO:0016567),2/506,0.0606730276520567,0.0920985445385066,0,0,5.521541950113379,15.472774250347072,PRKN;BTBD9
195,GO_Biological_Process_2018,ERBB signaling pathway (GO:0038127),1/80,0.0621377268635967,0.0921571503749879,0,0,16.79746835443038,46.67011894145101,NRG1
196,GO_Biological_Process_2018,positive regulation of binding (GO:0051099),1/81,0.0628910282964444,0.0921571503749879,0,0,16.586666666666666,45.88455452330808,PRKN
197,GO_Biological_Process_2018,positive regulation of protein catabolic process (GO:0045732),1/81,0.0628910282964444,0.0921571503749879,0,0,16.586666666666666,45.88455452330808,PRKN
198,GO_Biological_Process_2018,protein catabolic process (GO:0030163),1/81,0.0628910282964444,0.0921571503749879,0,0,16.586666666666666,45.88455452330808,PRKN
199,GO_Biological_Process_2018,positive regulation of protein targeting to mitochondrion (GO:1903955),1/81,0.0628910282964444,0.0921571503749879,0,0,16.586666666666666,45.88455452330808,NRG1
200,GO_Biological_Process_2018,BMP signaling pathway (GO:0030509),1/81,0.0628910282964444,0.0921571503749879,0,0,16.586666666666666,45.88455452330808,SMAD9
201,GO_Biological_Process_2018,negative regulation of cell death (GO:0060548),1/81,0.0628910282964444,0.0921571503749879,0,0,16.586666666666666,45.88455452330808,PRKN
693,GO_Biological_Process_2017b,regulation of chaperone-mediated autophagy (GO:1904714),1/56,0.0438872736413355,0.0924510600477314,0,0,24.15636363636364,75.5159546794018,PRKN
696,GO_Biological_Process_2017b,positive regulation of anaphase-promoting complex-dependent catabolic process (GO:1905786),1/57,0.0446543095355443,0.0927991176601204,0,0,23.723809523809525,73.75268481225066,PRKN
694,GO_Biological_Process_2017b,inositol phosphate metabolic process (GO:0043647),1/57,0.0446543095355443,0.0927991176601204,0,0,23.723809523809525,73.75268481225066,PTPRD
695,GO_Biological_Process_2017b,positive regulation of transcription factor catabolic process (GO:1901485),1/57,0.0446543095355443,0.0927991176601204,0,0,23.723809523809525,73.75268481225066,PRKN
697,GO_Biological_Process_2017b,negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),1/57,0.0446543095355443,0.0927991176601204,0,0,23.723809523809525,73.75268481225066,PRKN
698,GO_Biological_Process_2017b,negative regulation of JUN kinase activity (GO:0043508),1/57,0.0446543095355443,0.0927991176601204,0,0,23.723809523809525,73.75268481225066,PRKN
202,GO_Biological_Process_2018,modulation of chemical synaptic transmission (GO:0050804),1/82,0.0636437624710048,0.0928007571005785,0,0,16.381069958847736,45.12090295320282,BTBD9
203,GO_Biological_Process_2018,negative regulation of neuron death (GO:1901215),1/83,0.0643959297803682,0.0934372314460244,0,0,16.180487804878048,44.37830237840948,PRKN
699,GO_Biological_Process_2017b,protein localization to pre-autophagosomal structure (GO:0034497),1/58,0.0454207685297007,0.0941382057430087,0,0,23.30643274853801,72.05849833180837,ATG16L1
700,GO_Biological_Process_2017b,chondroitin sulfate biosynthetic process (GO:0030206),1/59,0.0461866510315301,0.0947072019822067,0,0,22.90344827586207,70.42957983562586,EXT1
703,GO_Biological_Process_2017b,proteasomal protein catabolic process (GO:0010498),1/59,0.0461866510315301,0.0947072019822067,0,0,22.90344827586207,70.42957983562586,PRKN
702,GO_Biological_Process_2017b,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),1/59,0.0461866510315301,0.0947072019822067,0,0,22.90344827586207,70.42957983562586,PRKN
701,GO_Biological_Process_2017b,phospholipid metabolic process (GO:0006644),1/59,0.0461866510315301,0.0947072019822067,0,0,22.90344827586207,70.42957983562586,PTPRD
705,GO_Biological_Process_2017b,positive regulation of protein ubiquitination (GO:0031398),1/60,0.0469519574385199,0.0952630504871023,0,0,22.51412429378531,68.86238459395226,PRKN
706,GO_Biological_Process_2017b,negative regulation of outer hair cell apoptotic process (GO:1905586),1/60,0.0469519574385199,0.0952630504871023,0,0,22.51412429378531,68.86238459395226,PRKN
707,GO_Biological_Process_2017b,positive regulation of protein catabolic process (GO:0045732),1/60,0.0469519574385199,0.0952630504871023,0,0,22.51412429378531,68.86238459395226,PRKN
704,GO_Biological_Process_2017b,response to endoplasmic reticulum stress (GO:0034976),1/60,0.0469519574385199,0.0952630504871023,0,0,22.51412429378531,68.86238459395226,PRKN
708,GO_Biological_Process_2017b,negative regulation of peptidyl-serine phosphorylation (GO:0033137),1/61,0.0477166881586132,0.0965605421792409,0,0,22.137777777777774,67.35361520384504,PRKN
709,GO_Biological_Process_2017b,negative regulation of motor neuron apoptotic process (GO:2000672),1/62,0.048480843602201,0.0966092901523535,0,0,21.77377049180328,65.90020061578312,PRKN
711,GO_Biological_Process_2017b,endoplasmic reticulum stress-induced pre-emptive quality control (GO:0061857),1/62,0.048480843602201,0.0966092901523535,0,0,21.77377049180328,65.90020061578312,PRKN
712,GO_Biological_Process_2017b,photoreceptor cell differentiation (GO:0046530),1/63,0.0492444241632619,0.0966092901523535,0,0,21.421505376344086,64.49927724978124,PTPRD
713,GO_Biological_Process_2017b,retinal bipolar neuron differentiation (GO:0060040),1/63,0.0492444241632619,0.0966092901523535,0,0,21.421505376344086,64.49927724978124,PTPRD
715,GO_Biological_Process_2017b,Rohon-Beard neuron differentiation (GO:1905275),1/63,0.0492444241632619,0.0966092901523535,0,0,21.421505376344086,64.49927724978124,PTPRD
716,GO_Biological_Process_2017b,medial motor column neuron differentiation (GO:0021526),1/63,0.0492444241632619,0.0966092901523535,0,0,21.421505376344086,64.49927724978124,PTPRD
717,GO_Biological_Process_2017b,glutamatergic neuron differentiation (GO:1905962),1/63,0.0492444241632619,0.0966092901523535,0,0,21.421505376344086,64.49927724978124,PTPRD
718,GO_Biological_Process_2017b,neuron differentiation involved in amphid sensory organ development (GO:0003387),1/63,0.0492444241632619,0.0966092901523535,0,0,21.421505376344086,64.49927724978124,PTPRD
719,GO_Biological_Process_2017b,response to manganese-induced endoplasmic reticulum stress (GO:1990737),1/63,0.0492444241632619,0.0966092901523535,0,0,21.421505376344086,64.49927724978124,PRKN
720,GO_Biological_Process_2017b,mechanoreceptor differentiation (GO:0042490),1/63,0.0492444241632619,0.0966092901523535,0,0,21.421505376344086,64.49927724978124,PTPRD
710,GO_Biological_Process_2017b,regulation of translation in response to endoplasmic reticulum stress (GO:0036490),1/62,0.048480843602201,0.0966092901523535,0,0,21.77377049180328,65.90020061578312,PRKN
714,GO_Biological_Process_2017b,neuron differentiation involved in salivary gland development (GO:0060705),1/63,0.0492444241632619,0.0966092901523535,0,0,21.421505376344086,64.49927724978124,PTPRD
204,GO_Biological_Process_2018,cellular response to BMP stimulus (GO:0071773),1/87,0.0673989383579737,0.096845076475535,0,0,15.424806201550387,41.60264604479508,SMAD9
205,GO_Biological_Process_2018,positive regulation of cellular component biogenesis (GO:0044089),1/87,0.0673989383579737,0.096845076475535,0,0,15.424806201550387,41.60264604479508,PTPRD
722,GO_Biological_Process_2017b,sperm mitochondrion organization (GO:0030382),1/64,0.0500074302501757,0.0973629513204179,0,0,21.08042328042328,63.14817193770837,PRKN
721,GO_Biological_Process_2017b,mitochondrion organization (GO:0007005),1/64,0.0500074302501757,0.0973629513204179,0,0,21.08042328042328,63.14817193770837,PRKN
723,GO_Biological_Process_2017b,GABAergic neuron differentiation (GO:0097154),1/64,0.0500074302501757,0.0973629513204179,0,0,21.08042328042328,63.14817193770837,PTPRD
206,GO_Biological_Process_2018,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),1/88,0.0681482773262192,0.097448744389183,0,0,15.246743295019158,40.953810596681016,PRKN
207,GO_Biological_Process_2018,regulation of neuron apoptotic process (GO:0043523),1/89,0.0688970518062023,0.0975766858116549,0,0,15.072727272727272,40.3216841439866,PRKN
208,GO_Biological_Process_2018,peptidyl-threonine modification (GO:0018210),1/89,0.0688970518062023,0.0975766858116549,0,0,15.072727272727272,40.3216841439866,GALNTL6
727,GO_Biological_Process_2017b,keratan sulfate biosynthetic process (GO:0018146),1/65,0.0507698622569058,0.0978589095001859,0,0,20.75,61.84438653446941,EXT1
726,GO_Biological_Process_2017b,potassium ion transport (GO:0006813),1/65,0.0507698622569058,0.0978589095001859,0,0,20.75,61.84438653446941,KCND3
724,GO_Biological_Process_2017b,ER overload response (GO:0006983),1/65,0.0507698622569058,0.0978589095001859,0,0,20.75,61.84438653446941,PRKN
725,GO_Biological_Process_2017b,mitochondrion disassembly (GO:0061726),1/65,0.0507698622569058,0.0978589095001859,0,0,20.75,61.84438653446941,PRKN
732,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990441),1/66,0.0515317205977756,0.0981011273602099,0,0,20.42974358974359,60.58558396287635,PRKN
731,GO_Biological_Process_2017b,regulation of cell migration (GO:0030334),1/66,0.0515317205977756,0.0981011273602099,0,0,20.42974358974359,60.58558396287635,NRG1
730,GO_Biological_Process_2017b,positive regulation of cellular protein catabolic process (GO:1903364),1/66,0.0515317205977756,0.0981011273602099,0,0,20.42974358974359,60.58558396287635,PRKN
728,GO_Biological_Process_2017b,mitochondrial membrane organization (GO:0007006),1/66,0.0515317205977756,0.0981011273602099,0,0,20.42974358974359,60.58558396287635,PRKN
729,GO_Biological_Process_2017b,cardiac neuron differentiation (GO:0060945),1/66,0.0515317205977756,0.0981011273602099,0,0,20.42974358974359,60.58558396287635,PTPRD
209,GO_Biological_Process_2018,regulation of JNK cascade (GO:0046328),1/90,0.0696452622180501,0.0981666553168706,0,0,14.902621722846442,39.70566015899566,PRKN
210,GO_Biological_Process_2018,regulation of protein catabolic process (GO:0042176),1/91,0.0703929089335409,0.098750241916247,0,0,14.736296296296295,39.10516049943563,PRKN
734,GO_Biological_Process_2017b,noradrenergic neuron differentiation (GO:0003357),1/67,0.0522930056729502,0.0990611974787336,0,0,20.11919191919192,59.3695755904207,PTPRD
733,GO_Biological_Process_2017b,positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),1/67,0.0522930056729502,0.0990611974787336,0,0,20.11919191919192,59.3695755904207,PRKN
318,WikiPathways_2019_Human,Parkin-Ubiquitin Proteasomal System pathway WP2359,1/70,0.0545734252963437,0.0992244096297158,0,0,19.24154589371981,55.958422143360416,PRKN
736,GO_Biological_Process_2017b,neuron fate commitment (GO:0048663),1/68,0.0530537178751864,0.0997668694677286,0,0,19.817910447761196,58.19430975162623,PTPRD
735,GO_Biological_Process_2017b,mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),1/68,0.0530537178751864,0.0997668694677286,0,0,19.817910447761196,58.19430975162623,PRKN
737,GO_Biological_Process_2017b,amacrine cell differentiation (GO:0035881),1/68,0.0530537178751864,0.0997668694677286,0,0,19.817910447761196,58.19430975162623,PTPRD
211,GO_Biological_Process_2018,proteolysis involved in cellular protein catabolic process (GO:0051603),1/93,0.0718865129143563,0.1003698482200446,0,0,14.414492753623188,37.94855381599624,PRKN
212,GO_Biological_Process_2018,positive regulation of protein localization to membrane (GO:1905477),1/95,0.0733778669070871,0.1019711202089097,0,0,14.106382978723405,36.84774749640788,PRKN
213,GO_Biological_Process_2018,regulation of cell death (GO:0010941),1/96,0.0741227011346479,0.1020479978411896,0,0,13.95719298245614,36.31708280615695,PRKN
214,GO_Biological_Process_2018,positive regulation of protein metabolic process (GO:0051247),1/96,0.0741227011346479,0.1020479978411896,0,0,13.95719298245614,36.31708280615695,PRKN
752,GO_Biological_Process_2017b,negative regulation of I-kappaB phosphorylation (GO:1903720),1/73,0.0568486999685374,0.1021016395583798,0,0,18.43703703703704,52.8656580429068,PRKN
762,GO_Biological_Process_2017b,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),1/74,0.0576059834084244,0.1021016395583798,0,0,18.183561643835617,51.89822766625515,PRKN
761,GO_Biological_Process_2017b,BMP signaling pathway involved in heart induction (GO:0003130),1/74,0.0576059834084244,0.1021016395583798,0,0,18.183561643835617,51.89822766625515,SMAD9
760,GO_Biological_Process_2017b,BMP signaling pathway involved in Malpighian tubule cell chemotaxis (GO:0061353),1/74,0.0576059834084244,0.1021016395583798,0,0,18.183561643835617,51.89822766625515,SMAD9
759,GO_Biological_Process_2017b,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway (GO:0072101),1/74,0.0576059834084244,0.1021016395583798,0,0,18.183561643835617,51.89822766625515,SMAD9
758,GO_Biological_Process_2017b,BMP signaling pathway involved in renal system segmentation (GO:0061151),1/74,0.0576059834084244,0.1021016395583798,0,0,18.183561643835617,51.89822766625515,SMAD9
757,GO_Biological_Process_2017b,BMP signaling pathway involved in forebrain neuron fate commitment (GO:0022024),1/74,0.0576059834084244,0.1021016395583798,0,0,18.183561643835617,51.89822766625515,SMAD9
756,GO_Biological_Process_2017b,BMP signaling pathway involved in heart development (GO:0061312),1/74,0.0576059834084244,0.1021016395583798,0,0,18.183561643835617,51.89822766625515,SMAD9
755,GO_Biological_Process_2017b,BMP signaling pathway involved in growth plate cartilage chondrocyte development (GO:0003434),1/74,0.0576059834084244,0.1021016395583798,0,0,18.183561643835617,51.89822766625515,SMAD9
754,GO_Biological_Process_2017b,BMP signaling pathway involved in determination of left/right symmetry (GO:0003154),1/74,0.0576059834084244,0.1021016395583798,0,0,18.183561643835617,51.89822766625515,SMAD9
753,GO_Biological_Process_2017b,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway (GO:0072097),1/74,0.0576059834084244,0.1021016395583798,0,0,18.183561643835617,51.89822766625515,SMAD9
751,GO_Biological_Process_2017b,ERBB2-EGFR signaling pathway (GO:0038134),1/73,0.0568486999685374,0.1021016395583798,0,0,18.43703703703704,52.8656580429068,NRG1
739,GO_Biological_Process_2017b,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:1903912),1/70,0.0545734252963437,0.1021016395583798,0,0,19.24154589371981,55.958422143360416,PRKN
749,GO_Biological_Process_2017b,positive regulation of autophagy of mitochondrion (GO:1903599),1/73,0.0568486999685374,0.1021016395583798,0,0,18.43703703703704,52.8656580429068,PRKN
738,GO_Biological_Process_2017b,neuron differentiation (GO:0030182),1/70,0.0545734252963437,0.1021016395583798,0,0,19.24154589371981,55.958422143360416,PTPRD
750,GO_Biological_Process_2017b,negative regulation of autophagy (GO:0010507),1/73,0.0568486999685374,0.1021016395583798,0,0,18.43703703703704,52.8656580429068,PRKN
741,GO_Biological_Process_2017b,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/71,0.0553324213162424,0.1021016395583798,0,0,18.965714285714284,54.89429252839914,PRKN
742,GO_Biological_Process_2017b,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903382),1/72,0.0560908460725308,0.1021016395583798,0,0,18.697652582159623,53.86387318021709,PRKN
743,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1/72,0.0560908460725308,0.1021016395583798,0,0,18.697652582159623,53.86387318021709,PRKN
740,GO_Biological_Process_2017b,negative regulation of neuron death (GO:1901215),1/71,0.0553324213162424,0.1021016395583798,0,0,18.965714285714284,54.89429252839914,PRKN
745,GO_Biological_Process_2017b,hair cell differentiation (GO:0035315),1/72,0.0560908460725308,0.1021016395583798,0,0,18.697652582159623,53.86387318021709,PTPRD
746,GO_Biological_Process_2017b,mitochondrion distribution (GO:0048311),1/72,0.0560908460725308,0.1021016395583798,0,0,18.697652582159623,53.86387318021709,PRKN
747,GO_Biological_Process_2017b,positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),1/72,0.0560908460725308,0.1021016395583798,0,0,18.697652582159623,53.86387318021709,NRG1
748,GO_Biological_Process_2017b,mitochondrion morphogenesis (GO:0070584),1/72,0.0560908460725308,0.1021016395583798,0,0,18.697652582159623,53.86387318021709,PRKN
744,GO_Biological_Process_2017b,mitochondrial genome maintenance (GO:0000002),1/72,0.0560908460725308,0.1021016395583798,0,0,18.697652582159623,53.86387318021709,PRKN
763,GO_Biological_Process_2017b,BMP signaling pathway involved in ureter morphogenesis (GO:0061149),1/75,0.0583626967999995,0.102969426162013,0,0,17.936936936936938,50.96024313698236,SMAD9
764,GO_Biological_Process_2017b,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),1/75,0.0583626967999995,0.102969426162013,0,0,17.936936936936938,50.96024313698236,PRKN
767,GO_Biological_Process_2017b,BMP signaling pathway involved in nephric duct formation (GO:0071893),1/76,0.0591188405269398,0.1033574286763506,0,0,17.69688888888889,50.05044051882733,SMAD9
765,GO_Biological_Process_2017b,BMP signaling pathway involved in spinal cord dorsal/ventral patterning (GO:0021919),1/76,0.0591188405269398,0.1033574286763506,0,0,17.69688888888889,50.05044051882733,SMAD9
766,GO_Biological_Process_2017b,ERBB signaling pathway (GO:0038127),1/76,0.0591188405269398,0.1033574286763506,0,0,17.69688888888889,50.05044051882733,NRG1
768,GO_Biological_Process_2017b,negative regulation of protein phosphorylation (GO:0001933),1/76,0.0591188405269398,0.1033574286763506,0,0,17.69688888888889,50.05044051882733,PRKN
215,GO_Biological_Process_2018,regulation of insulin secretion (GO:0050796),1/98,0.075610686071539,0.1036146438758128,0,0,13.6680412371134,35.29303731792002,PRKN
773,GO_Biological_Process_2017b,BMP signaling pathway involved in mesodermal cell fate specification (GO:0060803),1/78,0.0606294206121001,0.1041097623428267,0,0,17.235497835497835,48.31066980519067,SMAD9
770,GO_Biological_Process_2017b,regulation of autophagy of mitochondrion (GO:1903146),1/77,0.0598744149956941,0.1041097623428267,0,0,17.46315789473684,49.16762572200828,PRKN
771,GO_Biological_Process_2017b,positive regulation of autophagy (GO:0010508),1/78,0.0606294206121001,0.1041097623428267,0,0,17.235497835497835,48.31066980519067,PRKN
772,GO_Biological_Process_2017b,mitochondrial respiratory chain supercomplex assembly (GO:0097250),1/78,0.0606294206121001,0.1041097623428267,0,0,17.235497835497835,48.31066980519067,PRKN
774,GO_Biological_Process_2017b,dopaminergic neuron differentiation (GO:0071542),1/78,0.0606294206121001,0.1041097623428267,0,0,17.235497835497835,48.31066980519067,PTPRD
775,GO_Biological_Process_2017b,negative regulation of insulin secretion (GO:0046676),1/78,0.0606294206121001,0.1041097623428267,0,0,17.235497835497835,48.31066980519067,PRKN
776,GO_Biological_Process_2017b,regulation of hair cycle by BMP signaling pathway (GO:0060902),1/78,0.0606294206121001,0.1041097623428267,0,0,17.235497835497835,48.31066980519067,SMAD9
769,GO_Biological_Process_2017b,peripheral nervous system neuron differentiation (GO:0048934),1/77,0.0598744149956941,0.1041097623428267,0,0,17.46315789473684,49.16762572200828,PTPRD
216,GO_Biological_Process_2018,glycosaminoglycan biosynthetic process (GO:0006024),1/99,0.0763538375668917,0.1041508567732717,0,0,13.527891156462584,34.798835876655495,EXT1
217,GO_Biological_Process_2018,cellular response to metal ion (GO:0071248),1/100,0.0770964289305897,0.1046813897406172,0,0,13.390572390572393,34.31599732708391,PRKN
218,GO_Biological_Process_2018,regulation of protein ubiquitination (GO:0031396),1/101,0.0778384605524974,0.1047281105615419,0,0,13.256,33.8441536611758,PRKN
219,GO_Biological_Process_2018,metal ion transport (GO:0030001),1/101,0.0778384605524974,0.1047281105615419,0,0,13.256,33.8441536611758,KCND3
778,GO_Biological_Process_2017b,mitochondrial fission (GO:0000266),1/79,0.0613838577642979,0.1049378144928464,0,0,17.013675213675214,47.4785046472436,PRKN
777,GO_Biological_Process_2017b,mitochondrial protein catabolic process (GO:0035694),1/79,0.0613838577642979,0.1049378144928464,0,0,17.013675213675214,47.4785046472436,PRKN
779,GO_Biological_Process_2017b,ERAD pathway (GO:0036503),1/80,0.0621377268635967,0.1059915650704271,0,0,16.79746835443038,46.67011894145101,PRKN
220,GO_Biological_Process_2018,regulation of cellular response to stress (GO:0080135),1/104,0.0800612009686615,0.1067482679582153,0,0,12.867961165048545,32.491137725835515,PRKN
221,GO_Biological_Process_2018,monovalent inorganic cation transport (GO:0015672),1/104,0.0800612009686615,0.1067482679582153,0,0,12.867961165048545,32.491137725835515,KCND3
222,GO_Biological_Process_2018,response to endoplasmic reticulum stress (GO:0034976),1/106,0.0815402364397426,0.107749598152517,0,0,12.6215873015873,31.638011389100345,PRKN
223,GO_Biological_Process_2018,positive regulation of cellular component organization (GO:0051130),1/106,0.0815402364397426,0.107749598152517,0,0,12.6215873015873,31.638011389100345,PTPRD
781,GO_Biological_Process_2017b,mitochondrial respiratory chain complex assembly (GO:0033108),1/82,0.0636437624710048,0.1080822486016404,0,0,16.381069958847736,45.12090295320282,PRKN
780,GO_Biological_Process_2017b,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/82,0.0636437624710048,0.1080822486016404,0,0,16.381069958847736,45.12090295320282,NRG1
320,WikiPathways_2019_Human,ErbB Signaling Pathway WP673,1/91,0.0703929089335409,0.1082967829746784,0,0,14.736296296296295,39.10516049943563,NRG1
319,WikiPathways_2019_Human,MicroRNAs in cardiomyocyte hypertrophy WP1544,1/84,0.0651475306269686,0.1082967829746784,0,0,15.984738955823293,43.655934613086224,NRG1
782,GO_Biological_Process_2017b,positive regulation of chaperone-mediated autophagy (GO:1904716),1/83,0.0643959297803682,0.1086417108548443,0,0,16.180487804878048,44.37830237840948,PRKN
783,GO_Biological_Process_2017b,peptidyl-N-phospho-arginine dephosphorylation (GO:0098628),1/83,0.0643959297803682,0.1086417108548443,0,0,16.180487804878048,44.37830237840948,PTPRD
784,GO_Biological_Process_2017b,peptidyl-histidine dephosphorylation (GO:0035971),1/83,0.0643959297803682,0.1086417108548443,0,0,16.180487804878048,44.37830237840948,PTPRD
787,GO_Biological_Process_2017b,activation of MAPK activity involved in conjugation with cellular fusion (GO:0071508),1/84,0.0651475306269686,0.1089560653218932,0,0,15.984738955823293,43.655934613086224,NRG1
785,GO_Biological_Process_2017b,activation of MAPK activity involved in osmosensory signaling pathway (GO:0000169),1/84,0.0651475306269686,0.1089560653218932,0,0,15.984738955823293,43.655934613086224,NRG1
788,GO_Biological_Process_2017b,regulation of translational initiation by eIF2 alpha dephosphorylation (GO:0036496),1/84,0.0651475306269686,0.1089560653218932,0,0,15.984738955823293,43.655934613086224,PTPRD
786,GO_Biological_Process_2017b,activation of MAPK activity involved in cell wall organization or biogenesis (GO:0000199),1/84,0.0651475306269686,0.1089560653218932,0,0,15.984738955823293,43.655934613086224,NRG1
225,GO_Biological_Process_2018,regulation of cell motility (GO:2000145),1/109,0.083754610332196,0.1096963037979204,0,0,12.269135802469137,30.42578893667829,NRG1
224,GO_Biological_Process_2018,regulation of Wnt signaling pathway (GO:0030111),1/109,0.083754610332196,0.1096963037979204,0,0,12.269135802469137,30.42578893667829,PRKN
226,GO_Biological_Process_2018,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),1/110,0.0844916220339589,0.1101740974539728,0,0,12.155963302752294,30.038636134005245,NRG1
790,GO_Biological_Process_2017b,neuron development (GO:0048666),1/86,0.0666490345194074,0.1109857572666591,0,0,15.607058823529412,42.26882712102443,PTPRD
789,GO_Biological_Process_2017b,activation of MAPK activity involved in innate immune response (GO:0035419),1/86,0.0666490345194074,0.1109857572666591,0,0,15.607058823529412,42.26882712102443,NRG1
229,GO_Biological_Process_2018,positive regulation of developmental process (GO:0051094),1/113,0.0866993238656356,0.1115782602792528,0,0,11.82857142857143,28.92451446353325,PRKN
228,GO_Biological_Process_2018,regulation of organelle organization (GO:0033043),1/113,0.0866993238656356,0.1115782602792528,0,0,11.82857142857143,28.92451446353325,PRKN
227,GO_Biological_Process_2018,negative regulation of gene expression (GO:0010629),2/618,0.0859871621725841,0.1115782602792528,0,0,4.49165120593692,11.020523474828398,PRKN;NRG1
791,GO_Biological_Process_2017b,negative regulation of MAPK cascade (GO:0043409),1/87,0.0673989383579737,0.1119926324870641,0,0,15.424806201550387,41.60264604479508,PRKN
230,GO_Biological_Process_2018,protein O-linked glycosylation (GO:0006493),1/115,0.0881683512530412,0.1129776275796546,0,0,11.619883040935672,28.218969740720745,GALNTL6
792,GO_Biological_Process_2017b,peptidyl-serine dephosphorylation (GO:0070262),1/88,0.0681482773262192,0.1129942404699247,0,0,15.246743295019158,40.953810596681016,PTPRD
794,GO_Biological_Process_2017b,peptidyl-threonine dephosphorylation (GO:0035970),1/89,0.0688970518062023,0.1137465245023168,0,0,15.072727272727272,40.3216841439866,PTPRD
793,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),1/89,0.0688970518062023,0.1137465245023168,0,0,15.072727272727272,40.3216841439866,SMAD9
231,GO_Biological_Process_2018,activation of MAPK activity (GO:0000187),1/117,0.0896351632087383,0.1143621047835626,0,0,11.4183908045977,27.541245280134497,NRG1
795,GO_Biological_Process_2017b,activation of MAPK activity by adrenergic receptor signaling pathway (GO:0071883),1/90,0.0696452622180501,0.1147361050643517,0,0,14.902621722846442,39.70566015899566,NRG1
321,WikiPathways_2019_Human,Senescence and Autophagy in Cancer WP615,1/105,0.0808009975910041,0.1154299965585773,0,0,12.743589743589745,32.05988937570945,ATG16L1
796,GO_Biological_Process_2017b,negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),1/91,0.0703929089335409,0.1157205389930918,0,0,14.736296296296295,39.10516049943563,NRG1
797,GO_Biological_Process_2017b,histone dephosphorylation (GO:0016576),1/92,0.0711399923667074,0.1164520894155657,0,0,14.573626373626372,38.5196337684351,PTPRD
798,GO_Biological_Process_2017b,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),1/92,0.0711399923667074,0.1164520894155657,0,0,14.573626373626372,38.5196337684351,PRKN
232,GO_Biological_Process_2018,enzyme linked receptor protein signaling pathway (GO:0007167),1/120,0.0918312340447472,0.1166611385289493,0,0,11.128851540616246,26.573502859289157,PTPRD
233,GO_Biological_Process_2018,sulfur compound biosynthetic process (GO:0044272),1/122,0.0932925210810863,0.1180110523076989,0,0,10.943801652892562,25.958865335590662,EXT1
322,WikiPathways_2019_Human,ESC Pluripotency Pathways WP3931,1/116,0.0889020339647334,0.1185360452863112,0,0,11.518260869565218,27.87672828746852,SMAD9
234,GO_Biological_Process_2018,negative regulation of macromolecule metabolic process (GO:0010605),1/124,0.094751603581391,0.1188409943224227,0,0,10.764769647696475,25.367142114588106,PRKN
235,GO_Biological_Process_2018,dephosphorylation (GO:0016311),1/124,0.094751603581391,0.1188409943224227,0,0,10.764769647696475,25.367142114588106,PTPRD
801,GO_Biological_Process_2017b,larval central nervous system remodeling (GO:0035193),1/95,0.0733778669070871,0.1191038639691876,0,0,14.106382978723405,36.84774749640788,PRKN
799,GO_Biological_Process_2017b,ventral cord development (GO:0007419),1/95,0.0733778669070871,0.1191038639691876,0,0,14.106382978723405,36.84774749640788,PRKN
800,GO_Biological_Process_2017b,central nervous system maturation (GO:0021626),1/95,0.0733778669070871,0.1191038639691876,0,0,14.106382978723405,36.84774749640788,PRKN
802,GO_Biological_Process_2017b,central nervous system segmentation (GO:0035283),1/95,0.0733778669070871,0.1191038639691876,0,0,14.106382978723405,36.84774749640788,PRKN
236,GO_Biological_Process_2018,protein dephosphorylation (GO:0006470),1/125,0.0954803191208905,0.1192496812649097,0,0,10.67741935483871,25.07949773430617,PTPRD
803,GO_Biological_Process_2017b,preganglionic parasympathetic fiber development (GO:0021783),1/96,0.0741227011346479,0.1200600894428855,0,0,13.95719298245614,36.31708280615695,PRKN
237,GO_Biological_Process_2018,positive regulation of protein kinase B signaling (GO:0051897),1/127,0.0969361006486535,0.1205591840000061,0,0,10.506878306878306,24.519936301690542,NRG1
805,GO_Biological_Process_2017b,negative regulation of tRNA processing (GO:2000236),1/98,0.075610686071539,0.1206953187601586,0,0,13.6680412371134,35.29303731792002,PRKN
804,GO_Biological_Process_2017b,peptidyl-tyrosine dephosphorylation (GO:0035335),1/97,0.0748669740700115,0.1206953187601586,0,0,13.811111111111112,35.79898585826624,PTPRD
806,GO_Biological_Process_2017b,negative regulation of snoRNA processing (GO:1902797),1/98,0.075610686071539,0.1206953187601586,0,0,13.6680412371134,35.29303731792002,PRKN
807,GO_Biological_Process_2017b,negative regulation of protein maturation (GO:1903318),1/98,0.075610686071539,0.1206953187601586,0,0,13.6680412371134,35.29303731792002,PRKN
808,GO_Biological_Process_2017b,negative regulation of production of siRNA involved in RNA interference (GO:1903704),1/98,0.075610686071539,0.1206953187601586,0,0,13.6680412371134,35.29303731792002,PRKN
809,GO_Biological_Process_2017b,negative regulation of histone gene expression (GO:0036208),1/98,0.075610686071539,0.1206953187601586,0,0,13.6680412371134,35.29303731792002,PRKN
810,GO_Biological_Process_2017b,suppression by virus of host gene expression (GO:0039657),1/98,0.075610686071539,0.1206953187601586,0,0,13.6680412371134,35.29303731792002,PRKN
811,GO_Biological_Process_2017b,phosphatidylinositol-mediated signaling (GO:0048015),1/99,0.0763538375668917,0.1213789871424196,0,0,13.527891156462584,34.798835876655495,NRG1
812,GO_Biological_Process_2017b,negative regulation of rhodopsin gene expression (GO:0045871),1/99,0.0763538375668917,0.1213789871424196,0,0,13.527891156462584,34.798835876655495,PRKN
813,GO_Biological_Process_2017b,protein lipidation involved in autophagosome assembly (GO:0061739),1/100,0.0770964289305897,0.1223072977479108,0,0,13.390572390572393,34.31599732708391,ATG16L1
238,GO_Biological_Process_2018,generation of neurons (GO:0048699),1/130,0.0991156549550441,0.122754116597042,0,0,10.260981912144702,23.71793009518094,PTPRD
814,GO_Biological_Process_2017b,negative regulation of rRNA processing (GO:2000233),1/101,0.0778384605524974,0.123230909827465,0,0,13.256,33.8441536611758,PRKN
325,WikiPathways_2019_Human,Mesodermal Commitment Pathway WP2857,1/147,0.1113736023410321,0.1237484470455912,0,0,9.058447488584475,19.88206882523314,EXT1
324,WikiPathways_2019_Human,NRF2 pathway WP2884,1/146,0.1106568970524479,0.1237484470455912,0,0,9.121379310344828,20.079082751033187,NRG1
323,WikiPathways_2019_Human,Endoderm Differentiation WP2853,1/141,0.1070652345753571,0.1237484470455912,0,0,9.449523809523807,21.113231324434445,EXT1
815,GO_Biological_Process_2017b,skeletal system development (GO:0001501),1/103,0.0793208461708807,0.1248089232607123,0,0,12.994771241830064,32.93205499555994,EXT1
816,GO_Biological_Process_2017b,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),1/103,0.0793208461708807,0.1248089232607123,0,0,12.994771241830064,32.93205499555994,PRKN
817,GO_Biological_Process_2017b,astrocyte differentiation (GO:0048708),1/103,0.0793208461708807,0.1248089232607123,0,0,12.994771241830064,32.93205499555994,PRKN
818,GO_Biological_Process_2017b,oligodendrocyte differentiation (GO:0048709),1/104,0.0800612009686615,0.1252072737258378,0,0,12.867961165048545,32.491137725835515,PRKN
819,GO_Biological_Process_2017b,positive regulation of Wnt signaling pathway by BMP signaling pathway (GO:0060804),1/104,0.0800612009686615,0.1252072737258378,0,0,12.867961165048545,32.491137725835515,SMAD9
820,GO_Biological_Process_2017b,spinal cord development (GO:0021510),1/104,0.0800612009686615,0.1252072737258378,0,0,12.867961165048545,32.491137725835515,PRKN
239,GO_Biological_Process_2018,mitochondrial transport (GO:0006839),1/135,0.1027372899233383,0.126709324238784,0,0,9.875621890547263,22.47276896823717,PRKN
242,GO_Biological_Process_2018,neuron differentiation (GO:0030182),1/139,0.1056247656497219,0.128662265976616,0,0,9.58743961352657,21.551245134644013,PTPRD
241,GO_Biological_Process_2018,cellular response to growth factor stimulus (GO:0071363),1/139,0.1056247656497219,0.128662265976616,0,0,9.58743961352657,21.551245134644013,SMAD9
240,GO_Biological_Process_2018,regulation of vesicle-mediated transport (GO:0060627),1/138,0.1049037145337728,0.128662265976616,0,0,9.657907542579077,21.775803449759422,PRKN
821,GO_Biological_Process_2017b,negative regulation of mRNA processing (GO:0050686),1/108,0.0830170424171289,0.1295670844202559,0,0,12.38442367601246,30.821231144674936,PRKN
243,GO_Biological_Process_2018,modification-dependent protein catabolic process (GO:0019941),1/141,0.1070652345753571,0.1298824157143676,0,0,9.449523809523807,21.113231324434445,PRKN
244,GO_Biological_Process_2018,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/142,0.1077846531420612,0.1302214584900005,0,0,9.382033096926714,20.899604518737647,PTPRD
822,GO_Biological_Process_2017b,mitochondrial fusion (GO:0008053),1/109,0.083754610332196,0.1304541506386325,0,0,12.269135802469137,30.42578893667829,PRKN
825,GO_Biological_Process_2017b,regulation of macroautophagy (GO:0016241),1/110,0.0844916220339589,0.1308093184501653,0,0,12.155963302752294,30.038636134005245,PRKN
824,GO_Biological_Process_2017b,microglia differentiation (GO:0014004),1/110,0.0844916220339589,0.1308093184501653,0,0,12.155963302752294,30.038636134005245,PRKN
823,GO_Biological_Process_2017b,skeletal system morphogenesis (GO:0048705),1/110,0.0844916220339589,0.1308093184501653,0,0,12.155963302752294,30.038636134005245,EXT1
245,GO_Biological_Process_2018,cellular protein complex assembly (GO:0043623),1/144,0.1092218603967254,0.1308893549693552,0,0,9.24988344988345,20.482701866982715,NRG1
246,GO_Biological_Process_2018,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),1/144,0.1092218603967254,0.1308893549693552,0,0,9.24988344988345,20.482701866982715,SMAD9
247,GO_Biological_Process_2018,skeletal system development (GO:0001501),1/146,0.1106568970524479,0.132074360998083,0,0,9.121379310344828,20.079082751033187,EXT1
826,GO_Biological_Process_2017b,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia (GO:2000777),1/112,0.0859639784104222,0.1322918709669372,0,0,11.935735735735737,29.28822973194941,PRKN
827,GO_Biological_Process_2017b,establishment of endothelial blood-brain barrier (GO:0014045),1/112,0.0859639784104222,0.1322918709669372,0,0,11.935735735735737,29.28822973194941,PRKN
828,GO_Biological_Process_2017b,embryonic skeletal system development (GO:0048706),1/112,0.0859639784104222,0.1322918709669372,0,0,11.935735735735737,29.28822973194941,EXT1
248,GO_Biological_Process_2018,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/148,0.1120897661366361,0.1332472721945553,0,0,8.996371882086168,19.688157234385223,PRKN
303,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.1056247656497219,0.1333247650435274,0,0,9.58743961352657,21.551245134644013,SMAD9
307,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.1333247650435274,0.1333247650435274,0,0,7.460263653483993,15.032187197608868,ATG16L1
306,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.1241820694172389,0.1333247650435274,0,0,8.05691056910569,16.806767724629594,PRKN
305,KEGG_2019_Human,Hippo signaling pathway,1/160,0.1206416330430784,0.1333247650435274,0,0,8.31236897274633,17.580085479925984,MOB1B
299,KEGG_2019_Human,ErbB signaling pathway,1/85,0.0658985654115678,0.1333247650435274,0,0,15.793650793650794,42.95302244203452,NRG1
301,KEGG_2019_Human,Autophagy,1/128,0.0976631674389916,0.1333247650435274,0,0,10.423622047244097,24.24775052402932,ATG16L1
296,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0245226967845343,0.1333247650435274,0,0,44.34222222222222,164.42788585185278,GALNTL6
297,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0415827005217073,0.1333247650435274,0,0,25.553846153846155,81.26304639681278,EXT1
298,KEGG_2019_Human,Mitophagy,1/65,0.0507698622569058,0.1333247650435274,0,0,20.75,61.84438653446941,PRKN
302,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.1041821184662259,0.1333247650435274,0,0,9.729411764705882,22.004181371864657,PRKN
304,KEGG_2019_Human,Parkinson disease,1/142,0.1077846531420612,0.1333247650435274,0,0,9.382033096926714,20.899604518737647,PRKN
300,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0696452622180501,0.1333247650435274,0,0,14.902621722846442,39.70566015899566,SMAD9
829,GO_Biological_Process_2017b,phosphatidylinositol 3-kinase signaling (GO:0014065),1/114,0.0874341146770611,0.1342862597928569,0,0,11.72330383480826,28.56816441905438,NRG1
250,GO_Biological_Process_2018,protein stabilization (GO:0050821),1/152,0.1149490139192979,0.1355574028689729,0,0,8.756291390728476,18.94219275931892,PRKN
249,GO_Biological_Process_2018,positive regulation of intracellular protein transport (GO:0090316),1/152,0.1149490139192979,0.1355574028689729,0,0,8.756291390728476,18.94219275931892,NRG1
830,GO_Biological_Process_2017b,bone development (GO:0060348),1/118,0.0903677393850297,0.1385159583814273,0,0,11.32022792022792,27.212332976423568,EXT1
831,GO_Biological_Process_2017b,cartilage development (GO:0051216),1/121,0.0925621533335787,0.1415980559924389,0,0,11.035555555555556,26.26324202929869,EXT1
252,GO_Biological_Process_2018,regulation of protein kinase B signaling (GO:0051896),1/163,0.1227675015182962,0.1436331243059908,0,0,8.157201646090535,17.109428178679863,NRG1
251,GO_Biological_Process_2018,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),1/163,0.1227675015182962,0.1436331243059908,0,0,8.157201646090535,17.109428178679863,PRKN
253,GO_Biological_Process_2018,mitochondrion organization (GO:0007005),1/167,0.1255944986395636,0.1463620929027986,0,0,7.959036144578313,16.51258703153532,PRKN
833,GO_Biological_Process_2017b,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/126,0.0962084846804202,0.146594351163249,0,0,10.591466666666667,24.79714134276482,NRG1
832,GO_Biological_Process_2017b,protein homotrimerization (GO:0070207),1/126,0.0962084846804202,0.146594351163249,0,0,10.591466666666667,24.79714134276482,ATG16L1
254,GO_Biological_Process_2018,peptidyl-serine modification (GO:0018209),1/170,0.1277091390297905,0.1482427653051686,0,0,7.816568047337278,16.086496667009623,GALNTL6
834,GO_Biological_Process_2017b,positive regulation of protein autophosphorylation (GO:0031954),1/128,0.0976631674389916,0.1485173611350346,0,0,10.423622047244097,24.24775052402932,MOB1B
835,GO_Biological_Process_2017b,negative regulation of RNA splicing (GO:0033119),1/129,0.0983896854030089,0.1493276524522044,0,0,10.341666666666669,23.980456297633246,PRKN
255,GO_Biological_Process_2018,negative regulation of Wnt signaling pathway (GO:0030178),1/174,0.130521202304442,0.1509151401645111,0,0,7.6342967244701345,15.545104589375237,PRKN
836,GO_Biological_Process_2017b,mRNA catabolic process (GO:0006402),1/132,0.1005659503466767,0.1523307420771861,0,0,10.103307888040712,23.206707623377085,PRKN
256,GO_Biological_Process_2018,positive regulation of MAP kinase activity (GO:0043406),1/177,0.1326246699793358,0.1527505926610249,0,0,7.503030303030303,15.15786319385963,NRG1
257,GO_Biological_Process_2018,negative regulation of protein phosphorylation (GO:0001933),1/178,0.1333247650435274,0.1529617459414113,0,0,7.460263653483993,15.032187197608868,PRKN
837,GO_Biological_Process_2017b,"negative regulation of gene expression, epigenetic (GO:0045814)",1/133,0.1012902769451659,0.1531270657347509,0,0,10.026262626262628,22.957783789683365,PRKN
258,GO_Biological_Process_2018,"negative regulation of transcription, DNA-templated (GO:0045892)",2/813,0.1361433880257803,0.1555924434580346,0,0,3.37731196054254,6.734517516275876,PRKN;NRG1
259,GO_Biological_Process_2018,phosphate-containing compound metabolic process (GO:0006796),1/183,0.1368173011185362,0.1557612351195643,0,0,7.253479853479853,14.427960691505726,PTPRD
326,WikiPathways_2019_Human,Circadian rhythm related genes WP3594,1/201,0.1492814860795021,0.1571384063994758,0,0,6.594666666666667,12.54253889208656,BTBD9
838,GO_Biological_Process_2017b,activation of MAPK activity (GO:0000187),1/137,0.1041821184662259,0.1571906327543253,0,0,9.729411764705882,22.004181371864657,NRG1
839,GO_Biological_Process_2017b,positive regulation of canonical Wnt signaling pathway (GO:0090263),1/141,0.1070652345753571,0.1605978518630356,0,0,9.449523809523807,21.113231324434445,PRKN
841,GO_Biological_Process_2017b,protein stabilization (GO:0050821),1/141,0.1070652345753571,0.1605978518630356,0,0,9.449523809523807,21.113231324434445,PRKN
840,GO_Biological_Process_2017b,negative regulation of protein kinase activity (GO:0006469),1/141,0.1070652345753571,0.1605978518630356,0,0,9.449523809523807,21.113231324434445,PRKN
260,GO_Biological_Process_2018,protein homooligomerization (GO:0051260),1/190,0.1416846896021475,0.1606845521924738,0,0,6.982363315696649,13.644593555126402,ATG16L1
842,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in heart development (GO:1905067),1/142,0.1077846531420612,0.1610503247529635,0,0,9.382033096926714,20.899604518737647,PRKN
843,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in neural crest cell differentiation (GO:0072336),1/142,0.1077846531420612,0.1610503247529635,0,0,9.382033096926714,20.899604518737647,PRKN
844,GO_Biological_Process_2017b,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway (GO:0090082),1/143,0.1085035282753908,0.1611873223513031,0,0,9.315492957746478,20.689454501587115,PRKN
845,GO_Biological_Process_2017b,activation of JUN kinase activity (GO:0007257),1/143,0.1085035282753908,0.1611873223513031,0,0,9.315492957746478,20.689454501587115,NRG1
846,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060829),1/143,0.1085035282753908,0.1611873223513031,0,0,9.315492957746478,20.689454501587115,PRKN
261,GO_Biological_Process_2018,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),2/848,0.1457769167271927,0.1646945318749964,0,0,3.231678486997636,6.223171497912824,PRKN;SMAD9
847,GO_Biological_Process_2017b,positive regulation by symbiont of host I-kappaB kinase/NF-kappaB cascade (GO:0085033),1/148,0.1120897661366361,0.16619463402182,0,0,8.996371882086168,19.688157234385223,PRKN
848,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),2/724,0.1124374274104721,0.166390127703405,0,0,3.811238622872972,8.328922387952455,PRKN;SMAD9
849,GO_Biological_Process_2017b,protein homooligomerization (GO:0051260),1/150,0.1135204707516634,0.167671040133204,0,0,8.874720357941834,19.30936894370364,ATG16L1
850,GO_Biological_Process_2017b,positive regulation of spinal cord association neuron differentiation by negative regulation of canonical Wnt signaling pathway (GO:1902844),1/151,0.1142350123267236,0.1684038135829903,0,0,8.815111111111111,19.124360997236487,PRKN
851,GO_Biological_Process_2017b,protein targeting to mitochondrion (GO:0006626),1/152,0.1149490139192979,0.1691329956713334,0,0,8.756291390728476,18.94219275931892,PRKN
262,GO_Biological_Process_2018,regulation of autophagy (GO:0010506),1/203,0.1506559312870363,0.1695595272279952,0,0,6.528712871287128,12.3572646565605,PRKN
263,GO_Biological_Process_2018,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),1/204,0.1513423729401834,0.1696869029935389,0,0,6.496223316912972,12.266237975819138,PRKN
264,GO_Biological_Process_2018,regulation of canonical Wnt signaling pathway (GO:0060828),1/213,0.1574969859003167,0.1759211616094104,0,0,6.2176100628930815,11.492313081250014,PRKN
266,GO_Biological_Process_2018,central nervous system development (GO:0007417),1/217,0.1602189159030007,0.1776209704392817,0,0,6.101234567901234,11.172667222816036,PRKN
265,GO_Biological_Process_2018,protein oligomerization (GO:0051259),1/217,0.1602189159030007,0.1776209704392817,0,0,6.101234567901234,11.172667222816036,ATG16L1
267,GO_Biological_Process_2018,ion transmembrane transport (GO:0034220),1/219,0.161576787209336,0.1784579440819532,0,0,6.044648318042814,11.018032548714526,KCND3
852,GO_Biological_Process_2017b,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),1/162,0.1220594146159803,0.1792529688931826,0,0,8.208281573498965,17.264046449033206,PRKN
853,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905240),1/164,0.1234750529957817,0.1809871974519918,0,0,8.106748466257669,16.957016636973467,PRKN
854,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in neuron differentiation (GO:1904081),2/770,0.1245388226318103,0.182200061193787,0,0,3.574404761904762,7.445977612394807,PRKN;PTPRD
855,GO_Biological_Process_2017b,negative regulation of translation (GO:0017148),1/166,0.124888551169166,0.1823656684686118,0,0,8.007676767676768,16.658638477439094,PRKN
856,GO_Biological_Process_2017b,negative regulation of gene expression (GO:0010629),1/169,0.127004792189416,0.1851052831342907,0,0,7.863492063492063,16.226555390741908,PRKN
857,GO_Biological_Process_2017b,positive regulation of NF-kappaB import into nucleus (GO:0042346),1/170,0.1277091390297905,0.1857806531923934,0,0,7.816568047337278,16.086496667009623,PRKN
858,GO_Biological_Process_2017b,membrane repolarization (GO:0086009),1/173,0.1298189843403039,0.1881399190345381,0,0,7.67906976744186,15.677698087388547,KCND3
859,GO_Biological_Process_2017b,protein homotetramerization (GO:0051289),1/173,0.1298189843403039,0.1881399190345381,0,0,7.67906976744186,15.677698087388547,ATG16L1
268,GO_Biological_Process_2018,activation of protein kinase activity (GO:0032147),1/233,0.171024409273981,0.1881904280486929,0,0,5.675862068965517,10.023282878841078,NRG1
860,GO_Biological_Process_2017b,brain development (GO:0007420),1/174,0.130521202304442,0.1888027147780953,0,0,7.6342967244701345,15.545104589375237,PRKN
861,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/179,0.1340243303271126,0.1935070387307187,0,0,7.417977528089888,14.908161099822989,PRKN
862,GO_Biological_Process_2017b,protein dephosphorylation (GO:0006470),1/186,0.1389064848057601,0.2001811210939085,0,0,7.134774774774775,14.083719656169295,PTPRD
864,GO_Biological_Process_2017b,ferredoxin metabolic process (GO:0006124),1/188,0.140296639319295,0.2006840610671177,0,0,7.057754010695187,13.861402380035642,PRKN
865,GO_Biological_Process_2017b,prosthetic group metabolic process (GO:0051189),1/188,0.140296639319295,0.2006840610671177,0,0,7.057754010695187,13.861402380035642,PRKN
866,GO_Biological_Process_2017b,cellular protein metabolic process (GO:0044267),1/188,0.140296639319295,0.2006840610671177,0,0,7.057754010695187,13.861402380035642,PRKN
863,GO_Biological_Process_2017b,rhodopsin metabolic process (GO:0046154),1/188,0.140296639319295,0.2006840610671177,0,0,7.057754010695187,13.861402380035642,PRKN
269,GO_Biological_Process_2018,protein deubiquitination (GO:0016579),1/257,0.1869885160813632,0.2049948176299389,0,0,5.1375,8.61408773707421,PRKN
867,GO_Biological_Process_2017b,protein repair (GO:0030091),1/194,0.1444544894393642,0.2062489099217589,0,0,6.836269430051813,13.226751015103009,PRKN
270,GO_Biological_Process_2018,protein modification by small protein removal (GO:0070646),1/261,0.18962101312444,0.2071137265123035,0,0,5.057435897435897,8.409139600143405,PRKN
868,GO_Biological_Process_2017b,CAAX-box protein maturation (GO:0080120),1/196,0.1458362449220826,0.2078368666079957,0,0,6.765470085470086,13.025362659212895,PRKN
869,GO_Biological_Process_2017b,proteolysis involved in cellular protein catabolic process (GO:0051603),1/198,0.1472159080488326,0.2094159872797969,0,0,6.696108291032149,12.82877260042208,PRKN
271,GO_Biological_Process_2018,regulation of programmed cell death (GO:0043067),1/268,0.1942086639075983,0.2113447224876805,0,0,4.923096129837703,8.068078791150558,PRKN
870,GO_Biological_Process_2017b,Notch receptor processing (GO:0007220),1/202,0.1499689691245871,0.2129393650001044,0,0,6.561525704809287,12.4493590856042,PRKN
272,GO_Biological_Process_2018,positive regulation of macromolecule metabolic process (GO:0010604),1/276,0.1994218759744748,0.2162229864045588,0,0,4.777939393939394,7.70362801172772,PRKN
273,GO_Biological_Process_2018,MAPK cascade (GO:0000165),1/278,0.2007202293953822,0.2168364521935516,0,0,4.742960288808664,7.616450689208224,NRG1
275,GO_Biological_Process_2018,negative regulation of signal transduction (GO:0009968),1/283,0.2039574817776819,0.2187370094427313,0,0,4.657683215130024,7.404988453662056,NRG1
274,GO_Biological_Process_2018,protein polyubiquitination (GO:0000209),1/283,0.2039574817776819,0.2187370094427313,0,0,4.657683215130024,7.404988453662056,PRKN
871,GO_Biological_Process_2017b,protein K33-linked ubiquitination (GO:1990390),1/214,0.1581782427325842,0.2220127716199858,0,0,6.188106416275431,11.4110709740405,PRKN
878,GO_Biological_Process_2017b,negative regulation of mRNA catabolic process (GO:1902373),1/215,0.1588589831160387,0.2220127716199858,0,0,6.158878504672897,11.330725094627836,PRKN
876,GO_Biological_Process_2017b,positive regulation of production of siRNA involved in RNA interference (GO:1903705),1/215,0.1588589831160387,0.2220127716199858,0,0,6.158878504672897,11.330725094627836,PRKN
875,GO_Biological_Process_2017b,positive regulation of tRNA processing (GO:2000237),1/214,0.1581782427325842,0.2220127716199858,0,0,6.188106416275431,11.4110709740405,PRKN
874,GO_Biological_Process_2017b,positive regulation of snoRNA processing (GO:1902798),1/214,0.1581782427325842,0.2220127716199858,0,0,6.188106416275431,11.4110709740405,PRKN
873,GO_Biological_Process_2017b,protein linear polyubiquitination (GO:0097039),1/214,0.1581782427325842,0.2220127716199858,0,0,6.188106416275431,11.4110709740405,PRKN
879,GO_Biological_Process_2017b,"negative regulation of transcription, DNA-templated (GO:0045892)",2/895,0.1589507781248147,0.2220127716199858,0,0,3.0540713485842264,5.616927987801659,PRKN;NRG1
877,GO_Biological_Process_2017b,positive regulation of rhodopsin gene expression (GO:0045872),1/215,0.1588589831160387,0.2220127716199858,0,0,6.158878504672897,11.330725094627836,PRKN
872,GO_Biological_Process_2017b,positive regulation of histone gene expression (GO:0036207),1/214,0.1581782427325842,0.2220127716199858,0,0,6.188106416275431,11.4110709740405,PRKN
881,GO_Biological_Process_2017b,cellular protein catabolic process (GO:0044257),1/216,0.1595392073810582,0.2220301965537832,0,0,6.129922480620155,11.251261676273216,PRKN
880,GO_Biological_Process_2017b,negative regulation of gene silencing (GO:0060969),1/216,0.1595392073810582,0.2220301965537832,0,0,6.129922480620155,11.251261676273216,PRKN
883,GO_Biological_Process_2017b,protein K29-linked ubiquitination (GO:0035519),1/217,0.1602189159030007,0.2221740722323985,0,0,6.101234567901234,11.172667222816036,PRKN
882,GO_Biological_Process_2017b,protein K27-linked ubiquitination (GO:0044314),1/217,0.1602189159030007,0.2221740722323985,0,0,6.101234567901234,11.172667222816036,PRKN
885,GO_Biological_Process_2017b,positive regulation of rRNA processing (GO:2000234),1/220,0.1622549507336756,0.2241909803148099,0,0,6.016742770167427,10.94196663950869,PRKN
884,GO_Biological_Process_2017b,protein K6-linked ubiquitination (GO:0085020),1/220,0.1622549507336756,0.2241909803148099,0,0,6.016742770167427,10.94196663950869,PRKN
886,GO_Biological_Process_2017b,positive regulation of protein maturation (GO:1903319),1/222,0.1636097352606748,0.2256585078461186,0,0,5.961689291101056,10.792275321881728,PRKN
327,WikiPathways_2019_Human,Nuclear Receptors Meta-Pathway WP2882,1/319,0.2269053929911882,0.2269053929911882,0,0,4.122851153039832,6.115104024926112,NRG1
887,GO_Biological_Process_2017b,positive regulation of mRNA processing (GO:0050685),1/224,0.1649624656164899,0.2271179660541317,0,0,5.90762331838565,10.64575764539454,PRKN
890,GO_Biological_Process_2017b,isopeptide cross-linking via N6-glycyl-L-lysine (GO:0018276),1/226,0.1663131446737439,0.227757432581628,0,0,5.854518518518519,10.502320388633002,PRKN
889,GO_Biological_Process_2017b,actin ubiquitination (GO:0007014),1/226,0.1663131446737439,0.227757432581628,0,0,5.854518518518519,10.502320388633002,PRKN
888,GO_Biological_Process_2017b,protein ubiquitination (GO:0016567),1/226,0.1663131446737439,0.227757432581628,0,0,5.854518518518519,10.502320388633002,PRKN
891,GO_Biological_Process_2017b,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),1/227,0.1669877158704797,0.2282757605250706,0,0,5.8283185840707965,10.431728749892578,PRKN
895,GO_Biological_Process_2017b,MAPK cascade involved in osmosensory signaling pathway (GO:0000161),1/232,0.1703529030509593,0.2312360708667071,0,0,5.7007215007215,10.08961060394311,NRG1
894,GO_Biological_Process_2017b,ERK5 cascade (GO:0070375),1/232,0.1703529030509593,0.2312360708667071,0,0,5.7007215007215,10.08961060394311,NRG1
893,GO_Biological_Process_2017b,MAPK cascade involved in innate immune response (GO:0035420),1/232,0.1703529030509593,0.2312360708667071,0,0,5.7007215007215,10.08961060394311,NRG1
892,GO_Biological_Process_2017b,MAPK cascade (GO:0000165),1/232,0.1703529030509593,0.2312360708667071,0,0,5.7007215007215,10.08961060394311,NRG1
897,GO_Biological_Process_2017b,mitochondrial protein processing (GO:0034982),1/233,0.171024409273981,0.2313330167548059,0,0,5.675862068965517,10.023282878841078,PRKN
896,GO_Biological_Process_2017b,vacuolar protein processing (GO:0006624),1/233,0.171024409273981,0.2313330167548059,0,0,5.675862068965517,10.023282878841078,PRKN
898,GO_Biological_Process_2017b,histone ubiquitination (GO:0016574),1/235,0.1723658933731613,0.2327392360607834,0,0,5.626780626780627,9.892644315694556,PRKN
900,GO_Biological_Process_2017b,protein K11-linked ubiquitination (GO:0070979),1/236,0.173035871976467,0.2328283722405865,0,0,5.602553191489362,9.828314532069127,PRKN
899,GO_Biological_Process_2017b,sterol regulatory element binding protein cleavage (GO:0035103),1/236,0.173035871976467,0.2328283722405865,0,0,5.602553191489362,9.828314532069127,PRKN
901,GO_Biological_Process_2017b,protein monoubiquitination (GO:0006513),1/237,0.1737053421000519,0.2329162065376349,0,0,5.578531073446328,9.764632069659635,PRKN
902,GO_Biological_Process_2017b,MAPK cascade involved in axon regeneration (GO:1903616),1/237,0.1737053421000519,0.2329162065376349,0,0,5.578531073446328,9.764632069659635,NRG1
912,GO_Biological_Process_2017b,protein K33-linked deubiquitination (GO:1990168),1/243,0.1777115048485645,0.2330999918369317,0,0,5.438567493112948,9.395635497314764,PRKN
904,GO_Biological_Process_2017b,protein K6-linked deubiquitination (GO:0044313),1/242,0.1770450780603883,0.2330999918369317,0,0,5.461410788381743,9.45561848660738,PRKN
913,GO_Biological_Process_2017b,protein linear deubiquitination (GO:1990108),1/243,0.1777115048485645,0.2330999918369317,0,0,5.438567493112948,9.395635497314764,PRKN
903,GO_Biological_Process_2017b,protein K63-linked ubiquitination (GO:0070534),1/238,0.1743743040958122,0.2330999918369317,0,0,5.554711673699016,9.70158787977206,PRKN
905,GO_Biological_Process_2017b,monoubiquitinated protein deubiquitination (GO:0035520),1/242,0.1770450780603883,0.2330999918369317,0,0,5.461410788381743,9.45561848660738,PRKN
911,GO_Biological_Process_2017b,protein K29-linked deubiquitination (GO:0035523),1/243,0.1777115048485645,0.2330999918369317,0,0,5.438567493112948,9.395635497314764,PRKN
910,GO_Biological_Process_2017b,protein K11-linked deubiquitination (GO:0035871),1/243,0.1777115048485645,0.2330999918369317,0,0,5.438567493112948,9.395635497314764,PRKN
909,GO_Biological_Process_2017b,protein K27-linked deubiquitination (GO:1990167),1/243,0.1777115048485645,0.2330999918369317,0,0,5.438567493112948,9.395635497314764,PRKN
917,GO_Biological_Process_2017b,protein K63-linked deubiquitination (GO:0070536),1/244,0.1783774256599088,0.2330999918369317,0,0,5.4159122085048015,9.336239782955902,PRKN
916,GO_Biological_Process_2017b,nervous system development (GO:0007399),1/244,0.1783774256599088,0.2330999918369317,0,0,5.4159122085048015,9.336239782955902,NRG1
915,GO_Biological_Process_2017b,ganglion development (GO:0061548),1/244,0.1783774256599088,0.2330999918369317,0,0,5.4159122085048015,9.336239782955902,NRG1
914,GO_Biological_Process_2017b,stomatogastric nervous system development (GO:0007421),1/244,0.1783774256599088,0.2330999918369317,0,0,5.4159122085048015,9.336239782955902,NRG1
908,GO_Biological_Process_2017b,protein K48-linked deubiquitination (GO:0071108),1/243,0.1777115048485645,0.2330999918369317,0,0,5.438567493112948,9.395635497314764,PRKN
906,GO_Biological_Process_2017b,protein K48-linked ubiquitination (GO:0070936),1/243,0.1777115048485645,0.2330999918369317,0,0,5.438567493112948,9.395635497314764,PRKN
907,GO_Biological_Process_2017b,protein deubiquitination (GO:0016579),1/243,0.1777115048485645,0.2330999918369317,0,0,5.438567493112948,9.395635497314764,PRKN
918,GO_Biological_Process_2017b,ERK1 and ERK2 cascade (GO:0070371),1/245,0.1790428408476454,0.2331791052255652,0,0,5.39344262295082,9.277423362056076,NRG1
919,GO_Biological_Process_2017b,autonomic nervous system development (GO:0048483),1/245,0.1790428408476454,0.2331791052255652,0,0,5.39344262295082,9.277423362056076,NRG1
920,GO_Biological_Process_2017b,positive regulation of RNA splicing (GO:0033120),1/248,0.1810360564150891,0.2353774021855543,0,0,5.327125506072875,9.104372114397089,PRKN
922,GO_Biological_Process_2017b,stress-activated MAPK cascade (GO:0051403),1/250,0.1823623452960334,0.2359083359450365,0,0,5.28380187416332,8.991760896294297,NRG1
923,GO_Biological_Process_2017b,histone deubiquitination (GO:0016578),1/250,0.1823623452960334,0.2359083359450365,0,0,5.28380187416332,8.991760896294297,PRKN
921,GO_Biological_Process_2017b,signal peptide processing (GO:0006465),1/250,0.1823623452960334,0.2359083359450365,0,0,5.28380187416332,8.991760896294297,PRKN
924,GO_Biological_Process_2017b,positive regulation of I-kappaB phosphorylation (GO:1903721),1/252,0.1836866203524669,0.2372234242742914,0,0,5.241168658698539,8.881286728234658,PRKN
925,GO_Biological_Process_2017b,protein autoubiquitination (GO:0051865),1/253,0.1843480035577002,0.2376794494029881,0,0,5.22010582010582,8.82683345082116,PRKN
926,GO_Biological_Process_2017b,peripheral nervous system development (GO:0007422),1/255,0.1856692631818222,0.2389833087031468,0,0,5.178477690288714,8.719460369390827,NRG1
927,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),2/991,0.1865719967673894,0.2397450158460954,0,0,2.7437527083634263,4.606590884268487,PRKN;NRG1
928,GO_Biological_Process_2017b,neural tube development (GO:0021915),1/259,0.1883057651145809,0.2415702910205356,0,0,5.097157622739018,8.510664074569197,NRG1
929,GO_Biological_Process_2017b,regulation of cellular response to oxidative stress by transcription from RNA polymerase II promoter (GO:0100038),1/260,0.188963639082596,0.2420115709845208,0,0,5.077220077220077,8.459667485452375,PRKN
930,GO_Biological_Process_2017b,"positive regulation of gene expression, epigenetic (GO:0045815)",1/261,0.18962101312444,0.242450748124284,0,0,5.057435897435897,8.409139600143405,PRKN
931,GO_Biological_Process_2017b,apoptotic mitochondrial changes (GO:0008637),1/268,0.1942086639075983,0.2479054302529111,0,0,4.923096129837703,8.068078791150558,PRKN
932,GO_Biological_Process_2017b,determination of left/right asymmetry in nervous system (GO:0035545),1/270,0.1955149423340033,0.2491603645281266,0,0,4.885997521685254,7.974526804898503,NRG1
933,GO_Biological_Process_2017b,cellular protein modification process (GO:0006464),1/271,0.1961673368181892,0.249579235456805,0,0,4.867654320987654,7.928373172379217,PRKN
934,GO_Biological_Process_2017b,neurogenesis (GO:0022008),1/272,0.1968192352800145,0.2499960962123414,0,0,4.849446494464945,7.882627654249016,NRG1
935,GO_Biological_Process_2017b,MAPK import into nucleus (GO:0000189),1/273,0.1974706380757586,0.2504109571651479,0,0,4.831372549019608,7.837285256290291,NRG1
936,GO_Biological_Process_2017b,positive regulation of translation (GO:0045727),1/277,0.2000712996340878,0.2532922364825644,0,0,4.760386473429952,7.659849701537404,PRKN
937,GO_Biological_Process_2017b,positive regulation of gene expression (GO:0010628),1/282,0.2033110163119287,0.2569717927483559,0,0,4.674495848161329,7.4465577675923456,PRKN
938,GO_Biological_Process_2017b,synapse assembly (GO:0007416),1/285,0.2052489376131054,0.258996613583804,0,0,4.624413145539906,7.322904840962122,NRG1
939,GO_Biological_Process_2017b,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter (GO:0072367),1/303,0.216783974558008,0.2726597787670868,0,0,4.344812362030905,6.642583455842339,PRKN
940,GO_Biological_Process_2017b,regulation of cellular response to oxidative stress by regulation of transcription from RNA polymerase II promoter (GO:1900427),1/303,0.216783974558008,0.2726597787670868,0,0,4.344812362030905,6.642583455842339,PRKN
276,GO_Biological_Process_2018,cellular macromolecule biosynthetic process (GO:0034645),1/367,0.2565388586200831,0.2741353868286809,0,0,3.5734061930783243,4.861530255967055,EXT1
941,GO_Biological_Process_2017b,protein phosphorylation involved in cellular protein catabolic process (GO:1902002),1/310,0.2212272854003253,0.2777951743381935,0,0,4.24487594390507,6.403669857225148,PRKN
277,GO_Biological_Process_2018,organelle assembly (GO:0070925),1/376,0.261975195433932,0.2789376181598701,0,0,3.4860444444444445,4.669575544892206,ATG16L1
942,GO_Biological_Process_2017b,negative regulation of neuron apoptotic process by transcription from RNA polymerase II promoter (GO:0100069),1/317,0.2256469557111145,0.2828842322817387,0,0,4.149367088607595,6.177509854464187,PRKN
949,GO_Biological_Process_2017b,positive regulation of leukocyte proliferation (GO:0070665),1/327,0.2319199940423297,0.2834183819877464,0,0,4.020040899795501,5.874738306070472,NRG1
947,GO_Biological_Process_2017b,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway (GO:0038091),1/327,0.2319199940423297,0.2834183819877464,0,0,4.020040899795501,5.874738306070472,NRG1
963,GO_Biological_Process_2017b,positive regulation of myoblast proliferation (GO:2000288),1/330,0.2337925952583745,0.2834183819877464,0,0,3.982776089159068,5.788251737206288,NRG1
962,GO_Biological_Process_2017b,positive regulation of chondrocyte proliferation (GO:1902732),1/330,0.2337925952583745,0.2834183819877464,0,0,3.982776089159068,5.788251737206288,NRG1
961,GO_Biological_Process_2017b,positive regulation of glial cell proliferation (GO:0060252),1/330,0.2337925952583745,0.2834183819877464,0,0,3.982776089159068,5.788251737206288,NRG1
960,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in kidney development (GO:1901724),1/330,0.2337925952583745,0.2834183819877464,0,0,3.982776089159068,5.788251737206288,NRG1
959,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138),1/329,0.2331688709499275,0.2834183819877464,0,0,3.995121951219512,5.816866878073496,NRG1
958,GO_Biological_Process_2017b,positive regulation of mesenchymal cell proliferation (GO:0002053),1/329,0.2331688709499275,0.2834183819877464,0,0,3.995121951219512,5.816866878073496,NRG1
957,GO_Biological_Process_2017b,protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),1/329,0.2331688709499275,0.2834183819877464,0,0,3.995121951219512,5.816866878073496,PRKN
956,GO_Biological_Process_2017b,positive regulation of hair follicle cell proliferation (GO:0071338),1/328,0.2325446706517234,0.2834183819877464,0,0,4.007543323139654,5.845695003643075,NRG1
955,GO_Biological_Process_2017b,positive regulation of fat cell proliferation (GO:0070346),1/328,0.2325446706517234,0.2834183819877464,0,0,4.007543323139654,5.845695003643075,NRG1
954,GO_Biological_Process_2017b,positive regulation of chorionic trophoblast cell proliferation (GO:1901384),1/328,0.2325446706517234,0.2834183819877464,0,0,4.007543323139654,5.845695003643075,NRG1
953,GO_Biological_Process_2017b,positive regulation of hemocyte proliferation (GO:0035208),1/328,0.2325446706517234,0.2834183819877464,0,0,4.007543323139654,5.845695003643075,NRG1
952,GO_Biological_Process_2017b,positive regulation of secondary heart field cardioblast proliferation (GO:0072513),1/328,0.2325446706517234,0.2834183819877464,0,0,4.007543323139654,5.845695003643075,NRG1
951,GO_Biological_Process_2017b,positive regulation of mammary stem cell proliferation (GO:2000103),1/327,0.2319199940423297,0.2834183819877464,0,0,4.020040899795501,5.874738306070472,NRG1
950,GO_Biological_Process_2017b,positive regulation of germ cell proliferation (GO:1905938),1/327,0.2319199940423297,0.2834183819877464,0,0,4.020040899795501,5.874738306070472,NRG1
948,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in compound eye morphogenesis (GO:2000497),1/327,0.2319199940423297,0.2834183819877464,0,0,4.020040899795501,5.874738306070472,NRG1
945,GO_Biological_Process_2017b,positive regulation of cell proliferation in bone marrow (GO:0071864),1/327,0.2319199940423297,0.2834183819877464,0,0,4.020040899795501,5.874738306070472,NRG1
944,GO_Biological_Process_2017b,positive regulation of sebum secreting cell proliferation (GO:1904004),1/327,0.2319199940423297,0.2834183819877464,0,0,4.020040899795501,5.874738306070472,NRG1
946,GO_Biological_Process_2017b,positive regulation of synoviocyte proliferation (GO:1901647),1/327,0.2319199940423297,0.2834183819877464,0,0,4.020040899795501,5.874738306070472,NRG1
943,GO_Biological_Process_2017b,positive regulation of skeletal muscle cell proliferation (GO:0014858),1/327,0.2319199940423297,0.2834183819877464,0,0,4.020040899795501,5.874738306070472,NRG1
968,GO_Biological_Process_2017b,positive regulation of neural precursor cell proliferation (GO:2000179),1/335,0.2369040889465851,0.2849501600277958,0,0,3.9221556886227535,5.64829604534473,NRG1
967,GO_Biological_Process_2017b,positive regulation of trophectodermal cell proliferation (GO:1904075),1/335,0.2369040889465851,0.2849501600277958,0,0,3.9221556886227535,5.64829604534473,NRG1
966,GO_Biological_Process_2017b,positive regulation of osteoblast proliferation (GO:0033690),1/335,0.2369040889465851,0.2849501600277958,0,0,3.9221556886227535,5.64829604534473,NRG1
965,GO_Biological_Process_2017b,positive regulation of stem cell proliferation (GO:2000648),1/334,0.2362827394675979,0.2849501600277958,0,0,3.9341341341341343,5.67587816323022,NRG1
964,GO_Biological_Process_2017b,positive regulation of cardiac muscle cell proliferation (GO:0060045),1/334,0.2362827394675979,0.2849501600277958,0,0,3.9341341341341343,5.67587816323022,NRG1
969,GO_Biological_Process_2017b,positive regulation of growth plate cartilage chondrocyte proliferation (GO:0061913),1/337,0.2381453663961845,0.2859970054384085,0,0,3.8984126984126974,5.593731055692214,NRG1
278,GO_Biological_Process_2018,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/396,0.2739228054625174,0.2906134423544987,0,0,3.3061603375527424,4.281176591978886,NRG1
279,GO_Biological_Process_2018,protein modification by small protein conjugation (GO:0032446),1/398,0.2751075405587984,0.2908279714478726,0,0,3.289168765743073,4.244978846604293,PRKN
970,GO_Biological_Process_2017b,positive regulation of fibroblast proliferation (GO:0048146),1/345,0.2430915721395903,0.291483051507969,0,0,3.806201550387597,5.3831758114322,NRG1
972,GO_Biological_Process_2017b,translation (GO:0006412),1/348,0.2449386253789482,0.2923338702278159,0,0,3.772718539865514,5.30726278341378,PRKN
973,GO_Biological_Process_2017b,positive regulation of epithelial cell proliferation (GO:0050679),1/348,0.2449386253789482,0.2923338702278159,0,0,3.772718539865514,5.30726278341378,NRG1
971,GO_Biological_Process_2017b,positive regulation of smooth muscle cell proliferation (GO:0048661),1/347,0.244323410989379,0.2923338702278159,0,0,3.783815028901734,5.332388538075109,NRG1
280,GO_Biological_Process_2018,positive regulation of cell proliferation (GO:0008284),1/424,0.2903450991253739,0.305843947833134,0,0,3.082899921197793,3.812576294067865,NRG1
974,GO_Biological_Process_2017b,BMP signaling pathway (GO:0030509),1/381,0.2649792567780228,0.3152762453331105,0,0,3.4392982456140357,4.567744836730199,SMAD9
975,GO_Biological_Process_2017b,protein polyubiquitination (GO:0000209),1/381,0.2649792567780228,0.3152762453331105,0,0,3.4392982456140357,4.567744836730199,PRKN
281,GO_Biological_Process_2018,negative regulation of nucleic acid-templated transcription (GO:1903507),1/444,0.3018614031778995,0.3168474302860222,0,0,2.940707298720843,3.522341846080498,NRG1
976,GO_Biological_Process_2017b,dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),1/387,0.2685689983178705,0.3190550041649895,0,0,3.384801381692573,4.449820407279143,PTPRD
977,GO_Biological_Process_2017b,negative regulation of neuron apoptotic process (GO:0043524),1/399,0.2756992282765625,0.3270217000018919,0,0,3.2807370184254605,4.227048420650674,PRKN
979,GO_Biological_Process_2017b,chromatin organization involved in negative regulation of transcription (GO:0097549),1/412,0.2833500813191243,0.3301873892351454,0,0,3.1748580697485806,4.0037249629833145,NRG1
980,GO_Biological_Process_2017b,nitrogen catabolite repression of transcription (GO:0090295),1/412,0.2833500813191243,0.3301873892351454,0,0,3.1748580697485806,4.0037249629833145,NRG1
981,GO_Biological_Process_2017b,negative regulation of antisense RNA transcription (GO:0060195),1/412,0.2833500813191243,0.3301873892351454,0,0,3.1748580697485806,4.0037249629833145,NRG1
982,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase V promoter (GO:1904280),1/412,0.2833500813191243,0.3301873892351454,0,0,3.1748580697485806,4.0037249629833145,NRG1
983,GO_Biological_Process_2017b,negative regulation of transcription by pheromones (GO:0045996),1/412,0.2833500813191243,0.3301873892351454,0,0,3.1748580697485806,4.0037249629833145,NRG1
984,GO_Biological_Process_2017b,negative regulation of ncRNA transcription associated with protein coding gene TSS/TES (GO:1904388),1/412,0.2833500813191243,0.3301873892351454,0,0,3.1748580697485806,4.0037249629833145,NRG1
985,GO_Biological_Process_2017b,"negative regulation of mating-type specific transcription, DNA-templated (GO:0045894)",1/412,0.2833500813191243,0.3301873892351454,0,0,3.1748580697485806,4.0037249629833145,NRG1
986,GO_Biological_Process_2017b,negative regulation of transcription during mitotic cell cycle (GO:0007068),1/412,0.2833500813191243,0.3301873892351454,0,0,3.1748580697485806,4.0037249629833145,NRG1
987,GO_Biological_Process_2017b,negative regulation of transcription by transcription factor catabolism (GO:0010620),1/413,0.283935459225553,0.3301873892351454,0,0,3.166990291262136,3.9872671352285822,NRG1
988,GO_Biological_Process_2017b,carbon catabolite repression of transcription (GO:0045013),1/413,0.283935459225553,0.3301873892351454,0,0,3.166990291262136,3.9872671352285822,NRG1
989,GO_Biological_Process_2017b,negative regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090419),1/413,0.283935459225553,0.3301873892351454,0,0,3.166990291262136,3.9872671352285822,NRG1
990,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000080),1/413,0.283935459225553,0.3301873892351454,0,0,3.166990291262136,3.9872671352285822,PRKN
978,GO_Biological_Process_2017b,"negative regulation of cellular carbohydrate metabolic process by negative regulation of transcription, DNA-templated (GO:0010678)",1/412,0.2833500813191243,0.3301873892351454,0,0,3.1748580697485806,4.0037249629833145,NRG1
991,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, termination (GO:0060567)",1/414,0.284520388782244,0.3303693068540815,0,0,3.1591606133979013,3.970908078737404,NRG1
992,GO_Biological_Process_2017b,negative regulation of transcription by competitive promoter binding (GO:0010944),1/416,0.2856889044005563,0.3312272861546299,0,0,3.143614457831325,3.9384830541293088,NRG1
994,GO_Biological_Process_2017b,positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000081),1/419,0.2874383235910622,0.3322562930865202,0,0,3.120574162679426,3.89056637698372,NRG1
993,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase I promoter (GO:0016479),1/419,0.2874383235910622,0.3322562930865202,0,0,3.120574162679426,3.89056637698372,NRG1
995,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",1/422,0.2891837254479214,0.3337734316172865,0,0,3.097862232779097,3.8434961874990456,NRG1
996,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase III promoter (GO:0016480),1/423,0.2897646348369448,0.333943996202219,0,0,3.0903633491311218,3.827990710268719,NRG1
997,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, initiation (GO:2000143)",1/424,0.2903450991253739,0.3341135394412884,0,0,3.082899921197793,3.812576294067865,NRG1
998,GO_Biological_Process_2017b,negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930),1/430,0.2938185555713556,0.3376067158651493,0,0,3.038850038850039,3.7219618304505935,NRG1
999,GO_Biological_Process_2017b,negative regulation of transcription by transcription factor localization (GO:0010621),1/432,0.2949728280195734,0.3384286464331713,0,0,3.0244392884764117,3.692453349741653,NRG1
282,GO_Biological_Process_2018,cellular protein metabolic process (GO:0044267),1/484,0.3243703519194179,0.3386534534134353,0,0,2.691649413388544,3.0304455876122103,PRKN
283,GO_Biological_Process_2018,negative regulation of apoptotic process (GO:0043066),1/485,0.3249242593561339,0.3386534534134353,0,0,2.6859504132231407,3.01944653622211,PRKN
1000,GO_Biological_Process_2017b,positive regulation of cell proliferation (GO:0008284),1/442,0.3007177065592796,0.3445072091488924,0,0,2.9543461829176114,3.549893054289325,NRG1
284,GO_Biological_Process_2018,regulation of transcription from RNA polymerase II promoter (GO:0006357),2/1478,0.3334516814541632,0.3463217463523941,0,0,1.7913279132791329,1.967338970563223,PRKN;SMAD9
285,GO_Biological_Process_2018,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1/512,0.3397198213348268,0.3515981367661144,0,0,2.5405088062622307,2.74281982678163,NRG1
1019,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034396),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1021,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter by pheromones (GO:0046020),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1016,GO_Biological_Process_2017b,"negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000805)",1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1015,GO_Biological_Process_2017b,negative regulation of phosphatidylserine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900526),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1022,GO_Biological_Process_2017b,transfer RNA gene-mediated silencing (GO:0061587),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1023,GO_Biological_Process_2017b,negative regulation of mating type switching by negative regulation of transcription from RNA polymerase II promoter (GO:1900474),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1024,GO_Biological_Process_2017b,negative regulation of snRNA transcription from RNA polymerase II promoter (GO:1905381),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1020,GO_Biological_Process_2017b,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072365),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1017,GO_Biological_Process_2017b,negative regulation of cellular response to alkaline pH by negative regulation of transcription from RNA polymerase II promoter (GO:1900463),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1018,GO_Biological_Process_2017b,negative regulation of phosphatidylcholine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900473),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1025,GO_Biological_Process_2017b,negative regulation of inositol biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900471),1/482,0.323261258551243,0.3537334389389975,0,0,2.703118503118503,3.052616676496056,PRKN
1026,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0007070),1/482,0.323261258551243,0.3537334389389975,0,0,2.703118503118503,3.052616676496056,PRKN
1027,GO_Biological_Process_2017b,negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581),1/482,0.323261258551243,0.3537334389389975,0,0,2.703118503118503,3.052616676496056,PRKN
1028,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903758),1/482,0.323261258551243,0.3537334389389975,0,0,2.703118503118503,3.052616676496056,PRKN
1029,GO_Biological_Process_2017b,negative regulation of mitochondrial unfolded protein response by negative regulation of transcription from RNA polymerase II promoter (GO:1904490),1/483,0.3238160184062051,0.3537334389389975,0,0,2.6973720608575382,3.041502165018535,PRKN
1030,GO_Biological_Process_2017b,negative regulation of transcription initiation from RNA polymerase II promoter (GO:0060633),1/484,0.3243703519194179,0.3537334389389975,0,0,2.691649413388544,3.0304455876122103,PRKN
1031,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010768),1/484,0.3243703519194179,0.3537334389389975,0,0,2.691649413388544,3.0304455876122103,PRKN
1032,GO_Biological_Process_2017b,negative regulation of ceramide biosynthetic process by negative regulation of transcription from RNA Polymerase II promoter (GO:0061427),1/484,0.3243703519194179,0.3537334389389975,0,0,2.691649413388544,3.0304455876122103,PRKN
1033,GO_Biological_Process_2017b,positive regulation of gluconeogenesis by negative regulation of transcription from RNA polymerase II promoter (GO:0035949),1/484,0.3243703519194179,0.3537334389389975,0,0,2.691649413388544,3.0304455876122103,PRKN
1034,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000820),1/484,0.3243703519194179,0.3537334389389975,0,0,2.691649413388544,3.0304455876122103,PRKN
1014,GO_Biological_Process_2017b,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072362),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1013,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle (GO:0010674),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1003,GO_Biological_Process_2017b,negative regulation of filamentous growth of a population of unicellular organisms in response to starvation by negative regulation of transcription from RNA polymerase II promoter (GO:1902352),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1011,GO_Biological_Process_2017b,negative regulation of invasive growth in response to glucose limitation by negative regulation of transcription from RNA polymerase II promoter (GO:1900460),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1010,GO_Biological_Process_2017b,negative regulation of induction of conjugation with cellular fusion by negative regulation of transcription from RNA polymerase II promoter (GO:1902625),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1009,GO_Biological_Process_2017b,regulation of transport by negative regulation of transcription from RNA polymerase II promoter (GO:1900392),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1008,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901227),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1007,GO_Biological_Process_2017b,negative regulation of oligopeptide transport by negative regulation of transcription from RNA polymerase II promoter (GO:0035952),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1006,GO_Biological_Process_2017b,carbon catabolite repression of transcription from RNA polymerase II promoter (GO:0000437),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1005,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to copper ion (GO:0061398),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1004,GO_Biological_Process_2017b,negative regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0010688),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1012,GO_Biological_Process_2017b,negative regulation of cellular hyperosmotic salinity response by negative regulation of transcription from RNA polymerase II promoter (GO:1900464),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1002,GO_Biological_Process_2017b,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter (GO:0072368),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1001,GO_Biological_Process_2017b,negative regulation of pseudohyphal growth by negative regulation of transcription from RNA polymerase II promoter (GO:1900462),1/481,0.3227060719908149,0.3537334389389975,0,0,2.7088888888888887,3.0637895346311117,PRKN
1035,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/485,0.3249242593561339,0.3538370112479932,0,0,2.6859504132231407,3.01944653622211,PRKN
286,GO_Biological_Process_2018,positive regulation of cellular process (GO:0048522),1/519,0.3435057766450338,0.3542777347976655,0,0,2.5052767052767053,2.677016806661892,NRG1
1036,GO_Biological_Process_2017b,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),1/487,0.3260307973138797,0.3545412478547267,0,0,2.674622770919067,2.9976193954775723,PRKN
1037,GO_Biological_Process_2017b,negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),1/488,0.3265834283663897,0.354642004606319,0,0,2.668993839835729,2.9867905081817643,PRKN
1038,GO_Biological_Process_2017b,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter (GO:1900387),1/491,0.32823877383394,0.3559382484190827,0,0,2.6522448979591835,2.9546378587271773,PRKN
1039,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904489),1/492,0.3287897073734188,0.3560349218889127,0,0,2.6467073998642228,2.944030357038607,PRKN
1040,GO_Biological_Process_2017b,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter (GO:1900477),1/496,0.3309892084773108,0.3579139968246937,0,0,2.624781144781145,2.9021404741339407,PRKN
287,GO_Biological_Process_2018,negative regulation of cellular process (GO:0048523),1/534,0.3515501142136669,0.3613153951640465,0,0,2.432895559724828,2.54335633008482,PRKN
288,GO_Biological_Process_2018,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),1/565,0.3678831337163933,0.3767937978548527,0,0,2.2955082742316786,2.2954852334634266,PRKN
1041,GO_Biological_Process_2017b,negative regulation of neuron apoptotic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904089),1/534,0.3515501142136669,0.3796150392979512,0,0,2.432895559724828,2.54335633008482,PRKN
1086,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to nitrogen starvation (GO:0036278),1/725,0.4462258506268564,0.4524999817711818,0,0,1.7734806629834254,1.4310748641656534,PRKN
1074,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000721),1/721,0.4443835401942144,0.4524999817711818,0,0,1.7837037037037038,1.4467036759170453,PRKN
1073,GO_Biological_Process_2017b,positive regulation of posterior gap gene transcription (GO:0007360),1/721,0.4443835401942144,0.4524999817711818,0,0,1.7837037037037038,1.4467036759170453,PRKN
1072,GO_Biological_Process_2017b,positive regulation of terminal gap gene transcription (GO:0007363),1/721,0.4443835401942144,0.4524999817711818,0,0,1.7837037037037038,1.4467036759170453,PRKN
1071,GO_Biological_Process_2017b,transcriptional activation by promoter-enhancer looping (GO:0071733),1/721,0.4443835401942144,0.4524999817711818,0,0,1.7837037037037038,1.4467036759170453,PRKN
1070,GO_Biological_Process_2017b,positive regulation of transcription via serum response element binding (GO:0010735),1/721,0.4443835401942144,0.4524999817711818,0,0,1.7837037037037038,1.4467036759170453,PRKN
1069,GO_Biological_Process_2017b,positive regulation of filamentous growth of a population of unicellular organisms in response to starvation by positive regulation of transcription from RNA polymerase II promoter (GO:1904741),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1068,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle (GO:0010673),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1067,GO_Biological_Process_2017b,positive regulation of ethanol catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0061425),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1066,GO_Biological_Process_2017b,positive regulation of peroxisome organization by positive regulation of transcription from RNA polymerase II promoter (GO:0061424),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1065,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in stress response to cadmium ion (GO:1902901),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1075,GO_Biological_Process_2017b,positive regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090282),1/721,0.4443835401942144,0.4524999817711818,0,0,1.7837037037037038,1.4467036759170453,PRKN
1076,GO_Biological_Process_2017b,positive regulation of phospholipid biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900413),1/721,0.4443835401942144,0.4524999817711818,0,0,1.7837037037037038,1.4467036759170453,PRKN
1079,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1/722,0.4448446557281804,0.4524999817711818,0,0,1.781137309292649,1.4427749147149287,PRKN
1078,GO_Biological_Process_2017b,positive regulation of inositol biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900375),1/721,0.4443835401942144,0.4524999817711818,0,0,1.7837037037037038,1.4467036759170453,PRKN
1085,GO_Biological_Process_2017b,positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),1/725,0.4462258506268564,0.4524999817711818,0,0,1.7734806629834254,1.4310748641656534,PRKN
1080,GO_Biological_Process_2017b,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter (GO:0035948),1/723,0.4453054124468355,0.4524999817711818,0,0,1.778578024007387,1.4388605722314634,PRKN
1081,GO_Biological_Process_2017b,SREBP signaling pathway (GO:0032933),1/725,0.4462258506268564,0.4524999817711818,0,0,1.7734806629834254,1.4310748641656534,PRKN
1082,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process (GO:2000763),1/725,0.4462258506268564,0.4524999817711818,0,0,1.7734806629834254,1.4310748641656534,PRKN
1083,GO_Biological_Process_2017b,positive regulation of central gap gene transcription (GO:0007357),1/725,0.4462258506268564,0.4524999817711818,0,0,1.7734806629834254,1.4310748641656534,PRKN
1064,GO_Biological_Process_2017b,positive regulation of pseudohyphal growth by positive regulation of transcription from RNA polymerase II promoter (GO:1900461),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1084,GO_Biological_Process_2017b,positive regulation of SREBP signaling pathway (GO:2000640),1/725,0.4462258506268564,0.4524999817711818,0,0,1.7734806629834254,1.4310748641656534,PRKN
1090,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:1904488),1/729,0.448062432878222,0.4524999817711818,0,0,1.763369963369963,1.4156734301075076,PRKN
1089,GO_Biological_Process_2017b,regulation of potassium ion concentration by positive regulation of transcription from RNA polymerase II promoter (GO:0097301),1/728,0.4476038233850501,0.4524999817711818,0,0,1.7658872077028889,1.4195027115189531,PRKN
1088,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH (GO:0061402),1/727,0.4471448566870215,0.4524999817711818,0,0,1.7684113865932047,1.423345999141358,PRKN
1087,GO_Biological_Process_2017b,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),1/726,0.4466855325347199,0.4524999817711818,0,0,1.7709425287356322,1.4272033606066352,PRKN
1077,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0046022),1/721,0.4443835401942144,0.4524999817711818,0,0,1.7837037037037038,1.4467036759170453,PRKN
1063,GO_Biological_Process_2017b,positive regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901582),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1092,GO_Biological_Process_2017b,positive regulation of sodium ion transport by positive regulation of transcription from RNA polymerase II promoter (GO:0061423),1/731,0.4489785811348302,0.4524999817711818,0,0,1.7583561643835617,1.408056617877476,PRKN
1061,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901228),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1091,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in defense response to fungus (GO:1901244),1/730,0.4485206853403959,0.4524999817711818,0,0,1.760859625057156,1.411858087981496,PRKN
1042,GO_Biological_Process_2017b,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter (GO:0072369),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1043,GO_Biological_Process_2017b,positive regulation of oligopeptide transport by positive regulation of transcription from RNA polymerase II promoter (GO:0035951),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1044,GO_Biological_Process_2017b,positive regulation of invasive growth in response to glucose limitation by positive regulation of transcription from RNA polymerase II promoter (GO:0036095),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1045,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter by calcium-mediated signaling (GO:1900622),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1046,GO_Biological_Process_2017b,positive regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0060963),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1062,GO_Biological_Process_2017b,positive regulation of purine nucleotide biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900418),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1048,GO_Biological_Process_2017b,transcriptional activation by promoter-terminator looping (GO:0090203),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1049,GO_Biological_Process_2017b,positive regulation of cellular alcohol catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900422),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1050,GO_Biological_Process_2017b,positive regulation of starch catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0035957),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1047,GO_Biological_Process_2017b,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter (GO:0072363),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1052,GO_Biological_Process_2017b,positive regulation of ergosterol biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:0035961),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1053,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903757),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1054,GO_Biological_Process_2017b,positive regulation of mating type switching by positive regulation of transcription from RNA polymerase II promoter (GO:1900423),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1055,GO_Biological_Process_2017b,positive regulation of flocculation via cell wall protein-carbohydrate interaction by positive regulation of transcription from RNA polymerase II promoter (GO:1900524),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1056,GO_Biological_Process_2017b,positive regulation of sulfite transport by positive regulation of transcription from RNA polymerase II promoter (GO:0061426),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1057,GO_Biological_Process_2017b,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0072366),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1058,GO_Biological_Process_2017b,positive regulation of sulfate assimilation by positive regulation of transcription from RNA polymerase II promoter (GO:1900478),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1059,GO_Biological_Process_2017b,positive regulation of termination of RNA polymerase II transcription (GO:1904595),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1051,GO_Biological_Process_2017b,positive regulation of pyrimidine-containing compound salvage by positive regulation of transcription from RNA polymerase II promoter (GO:1904001),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1060,GO_Biological_Process_2017b,positive regulation of snRNA transcription from RNA polymerase II promoter (GO:1905382),1/720,0.4439220656196281,0.4524999817711818,0,0,1.786277236903106,1.4506469258995234,PRKN
1093,GO_Biological_Process_2017b,positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),1/733,0.4498933036157116,0.4528299439787385,0,0,1.7533697632058287,1.400495028893099,PRKN
1094,GO_Biological_Process_2017b,positive regulation of DNA repair by positive regulation of transcription from RNA polymerase II promoter (GO:1900404),1/739,0.4526289369010798,0.4549894528692732,0,0,1.738572719060524,1.3781363658406685,PRKN
1095,GO_Biological_Process_2017b,positive regulation of transcription of Notch receptor target (GO:0007221),1/744,0.4548988834874912,0.4566758322511142,0,0,1.726424405563033,1.359870180911553,PRKN
1096,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in defense response to Gram-negative bacterium (GO:1902097),1/756,0.460310800296078,0.4615079675270171,0,0,1.697924944812362,1.3173407816649254,PRKN
289,GO_Biological_Process_2018,regulation of cell proliferation (GO:0042127),1/740,0.4530836339731346,0.462457778124303,0,0,1.736129905277402,1.3744568026925883,NRG1
290,GO_Biological_Process_2018,positive regulation of gene expression (GO:0010628),1/771,0.4670048666326658,0.4750290052346016,0,0,1.6635497835497834,1.26665275709142,PRKN
291,GO_Biological_Process_2018,regulation of apoptotic process (GO:0042981),1/815,0.4861945303564753,0.4928547294024545,0,0,1.57002457002457,1.1322176716891168,PRKN
1097,GO_Biological_Process_2017b,"positive regulation of transcription, DNA-templated (GO:0045893)",1/1004,0.5614919588016063,0.5622211691377124,0,0,1.2616151545363907,0.7281510596256643,PRKN
292,GO_Biological_Process_2018,cellular protein modification process (GO:0006464),1/1001,0.5603821664750939,0.56611986783832,0,0,1.2656,0.7329548859348853,PTPRD
293,GO_Biological_Process_2018,regulation of gene expression (GO:0010468),1/1037,0.5735275676718145,0.5774291157512146,0,0,1.2193050193050192,0.6778717407464673,PRKN
294,GO_Biological_Process_2018,"positive regulation of transcription, DNA-templated (GO:0045893)",1/1120,0.6024442129928664,0.6044863967657236,0,0,1.1239201668156091,0.5695580202613767,PRKN
1098,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),1/1175,0.6205819471809811,0.6205819471809811,0,0,1.0681431005110733,0.5096085275377589,PRKN
295,GO_Biological_Process_2018,"regulation of transcription, DNA-templated (GO:0006355)",1/1598,0.7362845234741275,0.7362845234741275,0,0,0.7675641828428303,0.2349810659085813,NRG1
